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Abstract 
Di Wu. THE SIGNIFICANCE OF MIRNA PATHWAY IN PERIPHERAL NERVE 
REGENERATION FOLLOWING SCIATIC NERVE INJURY (under the direction of Dr. 
Alexander Murashov) Department of Physiology,  
microRNAs (miRNAs) are small (21-23 nucleotides) single-stranded RNAs that play important 
roles in post-transcriptional regulation of gene expression. The binding of miRNA to its specific 
target mRNAs at 3’ UTR causes either degradation of the mRNAs or inhibition of protein 
translation. Increasing evidence suggests that miRNA participate in the regulation of almost 
every cellular process investigated and changes of their expressions are observed in human 
pathologies. In neurons, the functions of miRNA pathway are just beginning to emerge. Recent 
studies have elucidated that miRNAs are dysregulated in neurological disorders and that they 
serve important roles in neural development. Subcellular localization of miRNA and miRNA 
machinery has also been identified in axons, which suggests its involvement in axonal functions. 
In the current study, we tested the hypothesis that miRNA pathway is involved in the post-
transcriptional regulation of gene expression in sciatic nerve after injury, and that it plays a 
critical role for peripheral nerve regeneration. We performed sciatic nerve crush as our injury 
model on adult mice. A corresponding injury-regulated expression of miRNA machinery, 
including components of RNA induced silencing complex (RISC) and Processing bodies (P-
bodies) were observed in both western blot analysis and immuofluorescent staining. Microarray 
analysis followed by RT-qPCR confirmation revealed a group of miRNAs following injury-
regulated expression patterns as well. The physiological importance of miRNA pathway in 
peripheral nerve regeneration was evaluated in inducible Dicer knockout mice. Blocking Dicer-
dependent miRNA biogenesis significantly delayed peripheral nerve regeneration in behavioral 
tests, electrophysiological studies, and histological evaluations. The detrimental effect of Dicer 
ablation on regenerative axon growth was also shown in dissociated dorsal root ganglion (DRG) 
neurons. A significant decrease in axon length and arborization was observed in vitro. To find 
the specific miRNAs involved in mediating axon growth, 19 miRNAs differentially expressed 
after nerve injury were identified with miRNA array analyses. Functional analysis for injury-
induced miRNAs has shown that miR-431 promoted axon growth in DRG neurons. 
Bioinformatics prediction followed by experimental approaches proved Kremen1 as a target gene 
for miR-431. A negative correlation between miR-431 and Kremen1 expression was confirmed 
at both mRNA and protein levels. Since Kremen1 inhibits the Wnt signaling, enhanced axon 
growth after overexpressing miR-431 might be mediated through Wnt signaling. The findings of 
this study improve our understanding of the significant role that miRNA pathway plays in 
regenerative axon growth. 
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CHAPTER I: Introduction 
Peripheral Nerve Injury 
Nerve injuries induce severe disability and greatly compromise the quality of life. 
Injuries to peripheral nerves, occurring in approximately 2.8% of trauma patients, cause partial 
or total loss of motor, sensory  and autonomic functions (Noble et al., 1998). Peripheral nerve 
injury leads to axon discontinuity and degeneration of myelinated fibers, which may finally 
result in eventual death of axotomized neurons (Navarro et al., 2007, Schuning et al., 2009). 
After peripheral nerve injury, the severed axons have the capability to regenerate and recover 
functional connections. However a number of clinical reports and experimental studies in recent 
years also indicate that the rate of axonal regeneration is far from satisfactory, especially after 
severe injuries (Navarro et al., 2007). When the lesion creates a laceration with an associated 
tissue gap longer than 4 cm, or the injury is left unrepaired, the probability of effective recovery 
is rare (Krarup et al., 2002, Navarro et al., 2007).  
The first detailed description on the repair of transected nerve trunks was recorded by 
Gabriele Ferrara in the 16
th
 century (Ferrara, 1596). He described applying gentle traction to the 
retracted nerve stumps, suturing using an alcohol disinfected needle, and finally, insulating the 
sutured segment with a mixture of oils. The injured limb was later immobilized to prevent 
damaging the suture (Artico et al., 1996, Ngeow, 2010). The whole procedure closely resembles 
modern surgical protocol, which includes disinfection, appropriate identification of injured nerve 
trunk, correct suturing technique, and wound immobilization (Artico et al., 1996, Ngeow, 2010). 
Over the years, different procedures have been developed to boost intrinsic neuronal growth 
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properties. Physical therapies, such as treadmill training, resistance training, and swimming help 
maintain muscle strength, relieve pain and enhance functional recovery (Bonetti et al., 2011). 
Electrical stimulations have been reported to facilitate rehabilitation after nerve injuries, in rats 
and human patients. One hour of low-frequency (2 Hz) or 20 Hz electrical stimulation after 
surgical repair can accelerate axon outgrowth at the site of injury and lead to earlier 
reinnervation of denervated muscles (Nix and Hopf, 1983, Ahlborn et al., 2007, Gordon et al., 
2009b). In animal models, pharmacological elevation of cAMP and overexpression of neuronal 
growth-associated genes such as GAP-43 or CAP-23 also accelerates axon outgrowth and 
promotes efficient regeneration (Caroni et al., 1997, Bomze et al., 2001, Cai et al., 2001). 
Despite the technological advances and extensive research on nerve regeneration, the 
functional outcome after nerve injury and repair are generally still insufficient, particularly when 
sensory functions are considered (Dahlin et al., 2009). The failure of functional recovery after 
peripheral nerve injuries can be explained by various factors. It can result from the damage to the 
neuronal cell body due to axotomy and retrograde degeneration (Krarup et al., 2002, 
Schmidhammer et al., 2007). The success of nerve regeneration and functional reinnervation of 
targets are based on the capacity of neuron to survive and shift from maintaining structure and 
supporting synaptic transmission toward a regenerative phenotype. Loss of neuron excludes the 
possibility of regeneration (Witzel et al., 2005, Navarro et al., 2007). The failure of functional 
recovery may also stem from the slow rate for axonal growth. At an average rate of 1-3mm/day 
for axonal regeneration in mammals, weeks or even months would have been anticipated for 
signs of functional recovery (Gordon et al., 2009a). Moreover, the progressive outgrowth of 
axons across the surgical repair site is surprisingly slow, probably due to a lack of organization 
of the extracellular matrix and the supports from Schwann cells (Gordon et al., 2009a). Since 
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peripheral nerve injuries always involve connective tissue scarring, regenerative attempts over 
long distance are always impeded by scar tissue (Deumens et al., 2010, Ngeow, 2010). 
Underlying diseases, such as diabetic generalized neuropathy, may impede axonal regeneration 
(Stoll and Muller, 1999). The failure of functional recovery may also result from the poor 
specificity of reinnervation. The selectivity of axon-target reconnection plays an important role 
in the recovery of function after nerve injury and regeneration. During the process of nerve 
regeneration, several sprouts emerge from each parent axon (Witzel et al., 2005). When axons 
reconnect the appropriate peripheral tissue, misdirected axonal sprouts are withdrawn gradually. 
The pruning of supernumerary axonal sprouts helps refine the selectivity of axon-target 
reconnection. However, the later refinement of distal reconnection and the reinnervation of 
targets are often far from adequate. When inappropriate distal reconnection is established, 
disturbed sensory localization or limited fine motor control are expected to occur (English et al., 
2011). Denervation atrophy also contributes to the failure of functional recovery. The 
progressive elapse of time during the slow regeneration is responsible for relentless atrophy of 
denervated target tissue (Gordon et al., 2009a). If the denervated skeletal muscles are replaced by 
adipose tissue, despite the fact that peripheral axons can regenerate through the injury site and 
reconnect the skeletal muscles, functional recovery is only limited.  
Currently, no medical treatment can overcome the limitations in axonal regeneration, and 
ensure the recovery of normal sensory and motor functions following severe nerve trauma, and it 
is generally considered that the gold standard treatment by surgical repair has reached a plateau 
(Navarro et al., 2007). Therefore, new therapeutic intervention strategies for peripheral nerve 
repair are needed.  A fundamental understanding of the multiple mechanisms involved in 
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successful axon regeneration and appropriate target re-innervation would facilitate the 
development of potentially therapeutic methods.  
Endogenous Mechanisms that Support Peripheral Axon Regeneration 
Cellular bases of peripheral nerve regeneration 
Nerve injuries are powerful stimuli that lead to profound cellular responses. Following 
injury, axons and myelin sheaths distal to the lesion site are degraded by a process of Wallerian 
degeneration (Glass, 2004, Makwana and Raivich, 2005). Myelin breaks down to vesicles, 
resulting in the collapse of the myelin sheath (Ngeow, 2010). Schwann cell cytoplasm withdraws 
from the myelin vesicles and significantly decreases the synthesis of myelin lipid and protein 
between 12 and 48 hours of injury (Ngeow, 2010). Injuries increase the permeability of the 
blood-nerve barrier, and the increased permeability allows the recruitment of macrophages to the 
site of the injured nerve. Infiltrating macrophages and injury-activated Schwann cells phagocyte 
the degenerative end products (Stoll and Muller, 1999). Wallerian degeneration takes place 
during the first few days. During this stage, elimination of myelin sheaths is important, because it 
clears the regeneration-inhibitory factors associated with myelin (Skaper, 2005, Raivich and 
Makwana, 2007). At the same time, degeneration also takes place retrogradely at a short segment 
of the proximal nerve stump. The remaining axons in the proximal nerve also exhibit a reduction 
in diameter, and chromatolysis at the neuron soma and dendritic arbor retraction occur (Hanz and 
Fainzilber, 2006, Navarro et al., 2007). Chromatolysis reflects a reactive alteration in neuronal 
biochemistry and function. The neuronal cells shift their functions from the synthesis of proteins 
required for neurotransmission to those required for regenerative axon growth (Deumens et al., 
2010).   
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Next, Schwann cells in the distal nerve dedifferentiate and proliferate, stimulated by the 
loss of axonal contact (Karanth et al., 2006, Navarro et al., 2007). Proliferated Schwann cells line 
up in bands of Bungner, which later provide support for regenerating axons (Geuna et al., 2009). 
Schwann cells not only pave a path for the regenerating axons to grow along, they also are able 
to attract injured neurons by secreting neurotrophic factors, such as nerve growth factor (NGF), 
that stimulate axon elongation (Ngeow, 2010). Proximal to the lesion, fine sprouts emerge from 
the severed axons and elongate (Witzel et al., 2005). In the absence of a guiding structure, 
regenerating axons make a tortuous course and form a neuroma, composed of immature axonal 
sprouts and connective tissue. If regenerating axons gain the distal endoneurial tube as a guiding 
structure, they elongate in association with the Schwann cells toward correct targets (Stoll and 
Muller, 1999, Navarro et al., 2007).  
Finally, regenerated axons reconnect with target peripheral tissue. Because several 
sprouts emerge from each parent axon, supernumerary axonal sprouts will be withdrawn 
gradually during the maturation of the nerve fiber (Witzel et al., 2005, Navarro et al., 2007). The 
regenerated axons will have smaller caliber and with shorter internodes than normal nerve 
structures (Geuna et al., 2009). For a successful regeneration, the regenerated axons are expected 
to replace the distal nerve segment lost during degeneration and perform a normal function. 
However, more often than not, the regenerated axons do not innervate target tissues adequately 
or relay information from sensory receptor accurately, which lead to a loss of complete recovery 
of motor and sensory function, especially when the lesion is severe (Choi et al., 2005, 
Bannerman and James, 2009). Usually, after nerve injury and repair, the diameter of regenerated 
axons, their conduction velocity and excitability remain below normal levels for a long time, 
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which consequently result in incomplete and inadequate functional recovery of reinnervated 
organs (van Meeteren et al., 1997, Xiao et al., 2007).  
Molecular bases of peripheral nerve regeneration 
Previous studies have demonstrated that to initiate a regenerative response to injury in the 
peripheral nerve system (PNS), the neuron must shift its physiology from synaptic transmission 
and maintenance of structure to the growth of the axon (Benowitz and Yin, 2007). A sequence of 
molecular responses would take place in response to injury for the successful nerve regeneration 
and recovery of function (Figure1.1). After nerve lesion, calcium and sodium ions influx into 
axoplasm through the ruptured plasmatic membrane, generating high frequency burst of action 
potentials at the lesioned site (Makwana and Raivich, 2005, Navarro et al., 2007). This first 
signal promotes an influx of calcium through voltage-dependent ion channels and leads to the 
activation of several protein kinase pathways, including calcium/calmodulin dependent kinase 2 
(CMAK2), protein kinase A (PKA), protein kinase C (PKC), and mitogen-activated protein 
kinase (MAPK), such as Erk1 and Erk2, c-jun N-terminal kinase (JNK) and P38 kinase 
(Makwana and Raivich, 2005, Raivich and Makwana, 2007). During the second phase of 
signaling, these activated proteins, termed “positive injury signals”, will incorporate to the 
retrograde transport system for trafficking back to cell body from the injured site and induce 
several signaling pathways genes in cell bodies (Hanz and Fainzilber, 2006). Several 
transcription factors have been demonstrated as the mediators in the regulation of gene 
expression. The modification in the activity of transcription factors is considered the downstream 
event influenced by axotomy-activated protein kinases (Dahlin et al., 2009). The activation of 
transcription factor cAMP responsive element binding protein (CREB) has been demonstrated in 
early stages after injury (Miletic et al., 2004).  Phosphorylation of CREB can be mediated by 
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multiple protein kinase pathways through activation of tyrosine kinase receptors (Trk) (Miletic et 
al., 2004). Two other transcription factors induced by nerve injury are ATF-3 and c-Jun. c-Jun 
up-regulation and phosphorylation is induced by activated JNK, leading to the formation of 
activating protein1 (AP-1) complexes. JNK pathways and the Erk1/2 pathways also show cross-
talk coordinated by MEKK1in PC12 cells (Waetzig and Herdegen, 2005).  ATF-3 is induced in 
all DRG neurons after peripheral axotomy, which makes it a reliable nerve injury marker. 
Inhibition of JNK reduces ATF-3 expression, which impairs nerve regeneration (Dahlin et al., 
2009). The modifications in the activity of transcription factors result in characteristic changes of 
gene expression.  Hundreds of genes have been found differentially expressed after nerve injury, 
including genes encoding for transcription factors, cytoskeletal proteins, cell adhesion and 
guidance molecules, trophic factors and receptors, cytokines, neuropeptides and neurotransmitter 
synthesizing enzymes, ion channels, and membrane transporters (Navarro et al., 2007, Raivich 
and Makwana, 2007, Dziennis and Alkayed, 2008, Hou et al., 2008). The changes in gene 
expression support the formation of new growth cones and elongation of the regenerating axon, 





Figure1.1.  Signal transduction in neuronal cells after nerve injury.  
The schematic diagram depicts several important signaling pathways activated by axon injury. 
Cellular injury induces sodium and calcium influx, which lead to depolarization. Among many 
other processes, the elevated intracellular calcium concentration leads to the activation of protein 
kinase pathways such as the MAPK Erk1 and Erk2, JNK and P38 kinase. Downstream events 
influenced by axotomy-activated kinases include up-regulation or activation of several 
transcription factors. The modifications in the activity of transcription factors result in 










Post-transcriptional Regulation of Gene Expression 
In the last decades, enormous efforts have been made in extending our understanding of 
the cellular and molecular requirement for successful peripheral axon regeneration. While 
previous studies gave an insight on regulation of expression at the transcriptional level, very little 
is known about the regulation of gene expression at the post-transcriptional level after peripheral 
nerve injury. 
Post-transcriptional regulation of gene expression by small RNAs was first observed in 
petunia. When  an exogenous RNA sequence was introduced into petunia, instead of being 
translated into protein, it ‘silenced’ endogenous homologous gene’s expression (Napoli et al., 
1990). This gene-silencing phenomenon was then characterized in Caenorhabditis elegans by 
Andrew Fire and Craig Mello, which they termed ‘RNA interference’ (RNAi) (Fire et al., 1998). 
Subsequent studies also showed that long double-stranded RNAs (dsRNAs) can induce a 
sequence-specific inhibition of gene expression in a number of invertebrates whereas shorter 
double-stranded RNA, termed small interfering RNAs (siRNAs), are required to induce highly 
specific gene silencing in mammalian cells (Elbashir et al., 2001). 
RNAi is an evolutionary conserved mechanism to selectively suppress gene expression 
(Filipowicz et al., 2008). It is originally recognized as a defensive response to foreign nucleic 
acids. Eukaryotic cells infected by viruses can process the dsRNA carried by viruses into 
siRNAs, which bind to and cause degradation of matched messenger RNA (mRNA), preventing 
the synthesis of protein necessary for viral replication. RNAi also protect the eukaryotic genome 
from endogenous transposable elements and it was later demonstrated that RNAi is required for 
normal development. Endogenous small RNAs, such as Let-7 and Lin-4, were initially identified 
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in C. elegans, whose expressions play an important role for development (Saugstad, 2010). The 
term ‘microRNA (miRNA)’ was then introduced in a series of subsequent studies. Both 
exogenous double-stranded siRNA and endogenous single-stranded miRNA can initiate RNAi 
utilizing the same RNAi machinery to produce gene silencing (Rana, 2007) .    
miRNA biogenesis and RISC assembly 
miRNAs, by definition, are endogenous, non-coding 21to 23 nucleotide small RNA 
molecules that regulate gene expression by binding to the 3’-untranslated region of target 
mRNAs, leading to their translational inhibition or degradation (Filipowicz et al., 2008, Carthew 
and Sontheimer, 2009). As showing in Figure 1.2, miRNAs are encoded in genomic DNA, 
located either in the introns of protein-coding genes or as independent entities. miRNA genes are 
first transcribed via RNA polymerase II into primary miRNA (pri-miRNAs). A single pri-
miRNAs often contains sequences for several different miRNAs and they fold into hairpin 
structures containing imperfect base-paired steam. Primary miRNAs are cleaved by enzymes 
including Drosha and DGCR8 in mammals (or Pasha in Drosophila) into ~70 nucleotide hairpins 
known as precursor miRNAs (pre-miRNAs), which are transported into the cytoplasm by 
Exportin-5. In the alternative way, when miRNA transcription occurs from introns of protein-
coding genes, it bypasses the Drosha/DGCR8 enzyme complex. This subclass of miRNAs is 
named ‘mirtron’ or ‘mitron’, and mitrons are spliced out from premature mRNA to form pre-
miRNAs (Sibley et al., 2012). Pre-miRNAs are further processed by Dicer, an endoribonuclease, 
which works with its cofactors in the cytoplasm. In mammals, Dicer forms complex with TAR 
RNA binding protein (TRBP) and in D. melanogaster Dicer complexes with Loquacious. 
(Bernstein et al., 2001, Lee et al., 2003, Filipowicz et al., 2008). The products of Dicer 
processing form miRNA duplexes with protruding 2-nucleotide 3’ end. The strand with the 5’ 
12 
 
terminus located at the thermodynamically less-stable end of the duplex are usually selected to 
function as the mature miRNA, while the other strand is degraded. Occasionally, both strands of 
the duplexes give rise to mature miRNA (Filipowicz et al., 2008). They are designated as miR-X 
and miR-X*, with the less predominately expressed transcript indicated by an asterisk (Saugstad, 
2010).  
The mature miRNA target specific mRNAs to either cause degradation of the mRNA or 
inhibit protein translation via RNA induced silencing complex (RISC), a ribonucleoprotein 
complex associated with miRNA. Although the assembly of RISC is a very dynamic process and 
its details are not well understood, proteins of Argonaute (AGO) family are considered the most 
important components of RISC (Peters and Meister, 2007, Filipowicz et al., 2008). The number 
of Ago proteins differs among species. For example, humans have eight Ago proteins, 
Drosophila has five, and C. elegans expresses 27 Ago proteins (Sasaki et al., 2003, Peters and 
Meister, 2007). In mammals, only Ago2 can cleave mRNA at the center of the siRNA-mRNA 
duplex. The significance of Ago2 in RNAi pathway is also evidenced by the pronounced 
reduction in RNAi function after Ago2 knockdown (Hammond et al., 2001). 
Apart from Ago proteins, RISC contains further regulatory factors and effectors 
mediating inhibitory function. The fragile X mental retardation protein (FMRP) is one of the 
conclusively identified subunit. Both miRNA and siRNA can co-immunoprecipitate with FMRP. 
The FMRP belongs to the fragile X gene family, which encodes three different proteins: FMRP, 
FXR1, and FXR2. The loss-of-function mutations in the FMRP gene results in fragile X 
syndrome (FXS), whereas the function of FXR1 and FXR2 remains unknown. However, it is 
suspected that all three fragile X protein functions similarly in regulating mRNA stability by 
binding with ribosomes, and FXR1 and FXR2 has the potential to associate with RISC as well 
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(Siomi et al., 2004). Other well identified components of RISC include Gemin3 and Gemin4, 
which are also components of the survival of motor neurons (SMN) complex. The SMN complex 
plays a critical role in the assembly of diverse ribonucleoprotein complexes in the nervous 
system. The functions of Gemin3 and Gemin4 are speculated to be involved in target mRNA 
recognition and translational repression (Dostie et al., 2003, Battle et al., 2007). RISC also 
recruits P-100. P-100 may be a nuclease in RISC since it showed ribonuclease activity in some 




Figure 1.2 Biogenesis of miRNAs 
miRNAs are processed from precursor molecules, which are either transcripts from independent 
miRNA genes (pri-miRNA) or are a portion of introns of protein coding transcripts (mitron). The 
precursor molecules are excised into pre-miRNA with a hairpin structure. The final processing of 
pre-miRNA by Dicer yields miRNA duplex. One strand of the duplex is degraded and the 
remaining mature miRNA binds to Argonaute proteins to form RNA-induced silencing 
complexes (RISCs). miRNAs target sequences within messenger RNAs, causing repression of 










The miRNA / target mRNA interaction 
miRNAs in RISC form complementary base pairs with mRNAs within their 3’- UTR, 
leading to their translational inhibition or degradation (Carthew and Sontheimer, 2009). The 
primary rule for mRNA targeting is the perfect base pairing of the ‘seed region’, which locates at 
the miRNA nucleotides 2 to 8. Perfect and contiguous Watson-Crick base pairing at this limited 
region associates miRNA with target mRNA (Filipowicz et al., 2008). The second rule requires a 
mismatch to be present in the central region of the miRNA-mRNA duplex. The bulge generated 
by the mismatch precludes the Ago-2 mediated endonucleolytic cleavage of mRNA (Filipowicz 
et al., 2008).  Some base pairing at the other half side of miRNAs, especially the 13-16 
nucleotides would stabilize the binding between miRNA and mRNA as well (Grimson et al., 
2007). Multiple miRNA binding sites within the mRNA 3’ UTR can improve the silencing 
efficiency (Doench and Sharp, 2004). A position of binding site close to the poly(A) tail or the 
termination codon increases the accessibility of mRNA to RISC (Grimson et al., 2007).  
Interactions between proteins bound to miRNA or mRNAs can also influence target selection 
and efficiency of repression. In addition, exceptions always exist in the target selection, which 
makes the prediction of targets for miRNAs by bioinformatics analyses alone insufficient 
(Ritchie et al., 2009).   
miRNA mediated translational repression and degradation 
The cytoplasmic foci termed P-bodies serve as the sites where miRNAs are believed to 
exert the majority of their function (Ding and Han, 2007). Several independent studies showed 
that Argonaute proteins interact with the RNA-binding protein GW182 proteins (Sen and Blau, 
2005, Eulalio et al., 2009b, Takimoto et al., 2009). Subsequent studies showed that GW182-
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containing foci, known as GW bodies (GWBs) coincide with mRNA-processing bodies or P-
bodies (Sen and Blau, 2005, Eulalio et al., 2009b, Takimoto et al., 2009).  Studies also showed 
that depleting GW182 suppresses repression of miRNA targets, irrespective of whether they are 
directed to a translational repression or degradation, leading to an upregulation of many mRNAs 
(Ding and Han, 2007, Eulalio et al., 2009b). Furthermore, when GW182 is directly tethered to an 
mRNA reporter, reporter expression is silenced independently of Argonaute proteins (Behm-
Ansmant et al., 2006). These observations suggested that once miRNA and their associated 
proteins are bound to an mRNA target, Ago2 together with mRNA are sequestered into P-bodies 
(Saugstad, 2010). The first proteins found in P-bodies are those functioning in the degradation of 
mRNA (Eulalio et al., 2007b). In eukaryotes, mRNA degradation can follow two pathways, and 
both are initiated by a gradual shortening of the mRNA poly(A) tail with deadenylases. 
Following deadenylation, mRNAs are exonucleolytically digested from 3’ to 5’, which is 
catalysed by the exosome (Eulalio et al., 2007b, Filipowicz et al., 2008). Alternatively, the cap 
structures at 5’ end are removed by decapping enzymes after deadenylation, followed by 5’ to 3’ 
degradation catalysed by exonuclease. The decapping enzymes and decapping coactivator, 
including DCP1 and DCP2, as well as exonuclease XRN1 colocalize in P-bodies. They form the 
decay machinery and destabilize mRNAs in P-bodies (Eulalio et al., 2007a). Consistent with its 
role in mediating mRNA degradation, the knockdown of the decay machinery component 
prevents miRNA- mediated degradation, but leads to an accumulation of deadenylated mRNAs 
(Filipowicz et al., 2008). Additional P-bodies components include decapping activators 
RCK/p54 and Pat1, translational repressor eIF4E-transporter (4E-T), and RAP55. RAP55 
responds to stress and has a putative role in translation regulation (Eulalio et al., 2007b). 
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In addition to mRNA degradation, an alternative mechanism to repress the expression of 
target mRNAs is through translation inhibition. Translation requires the participation of several 
initiation factors, many of which are multiprotein complexes. Initiation of translation starts with 
the binding between mRNA 7-methylguanosine cap and eukaryotic translation initiation factor 
(eIF) 4E. When miRNA is bound to the mRNA 3’ UTR, Ago proteins interact with the 7-
methylguanosine cap of the mRNA. The association of Ago instead of eIF4E with 7-
methylguanosine cap prevents effective recruitment of ribosomes and blocks the initiation of 
translation (Kiriakidou et al., 2007). Further studies also showed that multiple miRNA binding 
site at the 3’ UTR increase the likelihood of Ago association with 7-methylguanosine cap, 
therefore enhancing the translational repression (Filipowicz et al., 2008). Association of Ago 
with 7-methylguanosine cap has another function. The association disrupts the 3D structure of 
the mRNA, and possibly makes the poly (A) tail more vulnerable to exonucleolytic activity 
(Eulalio et al., 2007b).   
Targeting translation initiation is not the only mechanism by which miRNAs inhibit 
mRNA translation. The inhibition of translation occurs at post-initiation phase as well. Studies 
showed that mRNAs targeted by miRNAs remain associated with polysomes, despite a strong 
reduction in their protein expression level (Filipowicz et al., 2008). miRNA are speculated to be 
able to slow elongation and result in ribosome preferentially drop off from mRNA. How miRNA 
could modulate the elongation or terminate the translation of mRNA remains unclear.  
Recent findings indicate that under certain conditions, mRNAs sequestered into P-bodies can be 
freed when cells respond to a subsequent stress. The mRNAs released from P-bodies are 
recruited to the polysome and translation can resume (Saugstad, 2010). The ability of miRNA to 
disengage from repressed mRNA makes miRNA regulation more dynamic and wide-ranging. 
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One example in neuronal cell is the miR-134 mediated repression of LIMK1, a protein kinase 
that is important for the development of dendritic spine. In response to extracellular stimuli, 
miR-134 mediated repression of LIMK1 expression will be released at dendritic spines (Schratt 
et al., 2006). This observation also suggests that miRNA regulated mRNA translation is probably 
an important regulator of gene expression in response to synaptic activity.  
Functional Significance of miRNAs  
Bioinformatic predictions indicate that mammalian miRNAs can regulate at least 30% of 
all protein coding genes (Filipowicz et al., 2008). Therefore, it is no surprise that miRNA based 
regulations are involved in many cellular process. miRNA plays diverse roles in cell 
differentiation,  proliferation (Stefani and Slack, 2008), metabolism (Wang et al., 2011), and 
signal transduction (McCoy, 2012). 
miRNAs in development  
Early studies interrupted miRNA processing by Dicer gene ablation. Decreasing miRNA 
production in the entire organism induced embryonic lethality, suggesting miRNAs are necessary 
for normal fetal development (Bernstein et al., 2003). To better reveal the functions of miRNAs 
in different tissues at different developmental phases, conditional Dicer knockout mice were 
created. For example, Dicer was ablated from cardiac myocytes in early embryonic mouse heart 
by NKX2.5-Cre, in neonatal mouse heart by MYH6-Cre, and in adult mouse heart by MYH6 
driven tamoxifen activated Cre. Embryonic cardiac Dicer ablation caused intrauterine cardiac 
hypoplasia, a lethal cardiomyopathology. Postnatal hearts with Dicer ablation exhibited 
cardiomyocyte hypertrophy, cardiomyocyte apoptosis, and abnormal sarcomeric structure 
(Huang et al., 2011). The importance of Dicer in germ cell differentiation and maturation has 
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been demonstrated. When Dicer was deleted specifically in postnatal male germ cells, it resulted 
in abnormal spermatozoa and eventual male infertility (Korhonen et al., 2011). Smooth muscle 
cell specific knockout of Dicer developed severe dilation of the intestinal tract associated with 
destruction of smooth muscle layers, suggesting the role of miRNA pathway in the development 
of the gastrointestinal tract (Park et al., 2011). Dicer dependent miRNA pathway also regulated 
the development of nephrogenic and ureteric compartments in kidney, white adipose tissue, and 
skin (Yi et al., 2006, Mudhasani et al., 2011, Nagalakshmi et al., 2011). miRNA pathway is 
required for neural development as well. Dicer is essential for cellular and tissue morphogenesis 
in cortex and hippocampus. Dicer ablation in hippocampus at different embryonic time points 
resulted in abnormal hippocampal morphology and affected the number of hippocampal 
progenitors due to altered proliferation and increased apoptosis (Li et al., 2011). Dicer knockout 
in neocortex disrupted differentiation of newborn neurons and results in neuronal cell death (De 
Pietri Tonelli et al., 2008). Dicer-null neural stem cells were incapable of generating either glial 
or neuronal progeny, which blocked the differentiation (Andersson et al., 2010). Conditional 
knockout also resulted in the malformation of the midbrain and cerebellum and failure of neural 
crest and dopaminergic differentiation in mice (Huang et al., 2010).   
miRNA modulation of the cellular stress response 
Studies on cellular stress found crucial roles for specific miRNAs in modulating the 
stress response. For instance, recent studies have established that the regulation of miRNAs is a 
feature of the hypoxic response (Crosby et al., 2009). The hypoxic microenvironment induces the 
up-regulation of miR-210 and miR-373. Thus, miR-210 and miR-373 can serve as a marker of 
solid cancer, which is linked to an in vivo hypoxic signature. Mir-210 also participates in 
endothelial and neuronal cell responses to oxygen deprivation (Crosby et al., 2009). In addition, 
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specific miRNAs have been identified as key regulators of the response to ischemia, suggesting 
miRNA pathway plays a role in different components of tissue response to ischemia (Fasanaro et 
al., 2009). Other studies have shown the importance of miRNAs on immune system development 
and response, and miRNAs are found to be involved in the regulation of immunity (Aldrich et al., 
2009, Bi et al., 2009). Therefore, miRNAs can be considered as one of the key regulators 
mediating the shift of gene expression in response to injury, which is also a response to cellular 
stress.  
miRNAs in pathological events 
Dysregulation of miRNA has been documented in developmental defects and diseases, 
therefore miRNA may also play a role as diagnostic or prognostic biomarker. For instance, miR-
1, a muscle-enriched miRNA has increased expression level in both experiential acute 
myocardial infarction animal models as well as patients with acute myocardial infarction 
(Fichtlscherer et al., 2011). miR-423-5P increases circulating level in the plasma samples from 
patients with heart failure (Tijsen et al., 2010).  Extensive studies have documented profound 
alteration of miRNA expression in all major human cancers. For example, miR-15a and miR-16 
are severely down-regulated in 70% of patients with chronic lymphocytic leukemia. B-cell 
lymphoma 2 (BLC2), an anti-apoptotic factor was found to be the target gene of miR-15 and 
miR-16. Loss of miR-15 and miR-16 is responsible for the overexpression of BLC2 in chronic 
lymphocytic leukemia specimens (Ofir et al., 2011). Alternatively, some miRNAs are 
overexpressed in cancer specimens. These miRNAs are defined as oncomiR and the most 
characterized oncomiR is miR-21. miR-21 act as an oncogene by regulating the tumor-
suppressor genes PTEN an PDCD, and the upregulation of miRNA has been found in over 15 
different cancers (Koturbash et al., 2011). A number of miRNAs can work as both oncogene and 
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tumor suppressor. For example, miR-220 is up-regulated in pancreatic and thyroid cancer, but 
significantly down-regulated in lung cancer (Bloomston et al., 2007). The tumor type-selective 
miRNA dysregulation may be useful for diagnostic and prognostic purpose.  miRNA expression 
profile can help distinguish tumor histopathological subtypes, determine the stage of 
carcinogenic process, determine tumor’s aggressiveness,  modulate drug resistance, and predict 
overall survival and recurrent rates (Koturbash et al., 2011).  
miRNAs as effectors in neurological disorder  
A number of studies have shown the correlation between neurological diseases and the 
alteration of miRNA biogenesis.  Although no conclusion can be made that the altered 
expression of miRNAs is a consequence or the cause of neurological disorders, some studies 
showed the change in miRNA expression prior to the onset of the disease. This raises the 
possibility that restoring the expressing level of specific miRNAs can prevent the pathological 
development of the diseases. 
Mouse models and human samples have both implicated altered miRNAs in the 
pathology of Alzheimer’s disease (AD), particularly with respect to the regulation of β-amyloid 
precursor protein converting enzyme1 (BACE1) (Hutchison et al., 2009). BACE1 was shown to 
be targeted by miR-458-5p, and an endogenous natural BACE-antisense competes with miR-
485-5p for the binding on BACE1 mRNAs. In AD patients, BACE-antisense appeared to be up-
regulated while miR-485-5p was down-regulated in cortex and hippocampus. Therefore the 
down-regulation of BACE1 translation was blocked, and the increased expression of BACE1 
stimulated the formation of amyloid-β-peptide plaques in the brain region (Faghihi et al., 2010). 
miR-29 was found to regulate BACE1 expression in vitro and decreased expression of miR-29a 
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and miR-29b was observed in AD patients (Hebert and De Strooper, 2007, Hebert et al., 2008). 
In addition, miR-107 significantly decreases at early stage of AD, and it has multiple predicted 
binding sites on BACE1 (Wang et al., 2008c). In mouse models, miR-298 and miR-328 can also 
target BACE1 mRNA, and in vitro studies confirm the regulation of BACE1 protein expression 
by these miRNAs (Boissonneault et al., 2009). Increased expression of miRNAs, such as miR-9, 
miR-125b, miR-138, and miR-146a has also been observed in AD brains (Saugstad, 2010, Olde 
Loohuis et al., 2012). 
The pathological development of Parkinson’s disease (PD) is under the control of 
miRNAs as well.  Conditional knockout of Dicer in dopaminergic neurons results in loss of 
dopaminergic neurons and impaired locomotion, which mimics the phenotype of PD patients 
(Olde Loohuis et al., 2012). Gene screen of PD patients identified a disruption in the binding site 
of miR-433 in the 3’UTR of the fibroblast growth factor 20 (FGF20) gene. This disruption leads 
to an increased expression of FGF20 and subsequent increase of α-synuclein expression, which 
is correlated with cytotoxicity associated with PD (Wang et al., 2008a). Increased expression of 
α-synuclein may also result from insufficient expression of miR-7 in neurotoxin model of PD 
(Junn et al., 2009). Another report found a significant decrease of miR-133b expression in PD 
patient. Further studies revealed that miR-133b is specifically expressed in midbrain 
dopaminergic neurons and targets the transcription factor pituitary homeobox 3 (Pitx3) in a 
feedback loop. Lack of miR-133 disrupted midbrain dopaminergic maturation and function (Kim 
et al., 2007).  
Studies on miRNA expression in Huntington’s disease brains revealed dysregulated 
expression of several miRNAs in both mouse models of HD (Huntington's disease) and in human 
patients (Hutchison et al., 2009). Huntington’s disease is related to abnormal activation of 
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transcription factor REST. When Huntington protein can not bind to REST, REST can freely 
translocate to the nucleus and represses neuronal gene expression. Studies showed that several 
miRNAs with REST binding sites or REST cofactor binding sites are decreased in human HD, 
including miR-9 and miR-9*, which target REST and co-REST respectively (Packer et al., 2008). 
Decreased miR-124 is also observed in HD and miR-124 plays a role in maintaining neuronal 
identity through targeting PtBP-1 (Cao et al., 2007). 
Intellectual disability syndromes and mental diseases also appear to be influenced by 
miRNA expression. The studies in schizophrenia patients revealed a significant schizophrenia-
associated increase in global miRNA expression (Beveridge et al., 2010). miR-160b, 30b and 
181b are significantly upregulated in the frontal cortex of schizophrenia patients (Kim et al., 
2010, Santarelli et al., 2011). NMDA-regulated miRNA miR-132 was significantly down-
regulated in the prefrontal cortical tissue from schizophrenia patients (Miller et al., 2012). 
Twenty-eight miRNAs are differently expressed in the brains of autistic patients, and the 
predicted targets of dysregulated miRNAS included Neurexin and SHANK3, which are known 
genetic causes of autism (Abu-Elneel et al., 2008). In another study, differential expressions of 9 
miRNAs were observed in 6 autism samples in growing lymphoblastoid cell lines (Talebizadeh 
et al., 2008). These analyses revealed a subset of brain-related microRNAs implicated in 
schizophrenia and autism.   
miRNAs located in neurons 
In neurons, the functions of individual miRNAs are just beginning to emerge. To date, 
seven miRNAs have been identified to be specifically expressed in mammalian brain, which 
includes miR-9, miR-124a, miR-124b, miR-135, miR-153, miR-183, and miR-219, suggesting 
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their unique regulatory roles in brain function (Sempere et al., 2004). Functional analysis showed 
that transfection of brain-specific 124 into HeLa cells is sufficient to change the gene expression 
profile and shift it toward neuronal-like phenotype. The overexpression of miR-124 down-
regulated hundreds of nonneuronal transcripts, and allows the transition from nonneuronal to 
neuronal phenotypes during development (Lim et al., 2005). One direct target of miR-124 is 
small c-terminal domain phosphatase 1, an antineural factor of REST/SCP1 pathway. 
Suppression of small c-terminal domain phosphatase 1 induces neurogenesis during brain 
development (Visvanathan et al., 2007). MiR-124 also repressed the expression of SRY-box 
transcription factor Sox9. This repression promotes the adult neurogenesis in the subventricular 
zone stem cell niche (Cheng et al., 2009). MiR-124 also regulates early neurogenesis in forebrain 
and optic vesicle by targeting NeuroD1 (Liu et al., 2011). More recently, miRNA expression 
profiles within more specific brain regions, such as the cortex and hippocampus, have been 
identified. It was found that the expression of let-7g, miR-92b, miR-146b, miR-330*, and miR-
394 were significantly higher in rat hippocampus than in cortex (Olde Loohuis et al., 2012).  The 
specificity in miRNA expression further suggested the cell or tissue specific functions of 
miRNAs. For example, miR-449 has been identified in choroid plexus, the area in the brain 
ventricle that is responsible for the production of cerebrospinal fluid. Transcription factor E2f5 
which regulates cerebrospinal fluid production is targeted by miR-449 (Redshaw et al., 2009).  
miRNAs in axons and dendrites  
Subcellular localization of miRNAs within neuronal dendrites and axons has been shown 
in recent studies. With laser capture microdissection, RNA populations from dendrites and cell 
bodies were acquired. RT-qPCR analysis revealed that most miRNAs distributed with a gradient 
decrease from soma into the dendrites. A few miRNAs, such as miR-26a, miR-26b, and miR-
26 
 
292-5p, are enriched in dendrites (Kye et al., 2007). Enrichment of precursor miRNAs has been 
observed in dendrites as well. These dendritically enriched precursor miRNAs show a distinct 
structure which may allow them to bind to proteins that mediate dendritic transport (Smalheiser, 
2008).  The significant correlation between precursor and mature miRNAs enrichments suggests 
precursor miRNAs may be processed locally in dendrites. The identification of Dicer at 
postsynaptic densities further supported this hypothesis (Lugli et al., 2005, Lugli et al., 2008). It 
has been widely accepted that local protein synthesis in distal domains of neuron has a key role 
in synaptic formation, synaptic plasticity, and axonal regeneration (Schacher and Wu, 2002, 
Hanz et al., 2003). Regulation of local mRNA translation can alter the synaptic protein 
expression upon stimulations. One theory for miRNA based regulation of local protein synthesis 
suggests that precursor miRNAs are predominantly associated with postsynaptic densities. Upon 
stimulations, neuronal-mediated calcium influxes activate proteases such as calpain, resulting in 
release of Dicer from the postsynaptic density. The newly freed Dicer processes precursor 
miRNAs into mature miRNAs, which then incorporate into RISC and inhibit target mRNA 
translation. Meanwhile, activated protease can also degrade components of RISC. mRNA that 
are important for synaptic plasticity can be released from RISC and selectively enter the 
polysome compartment, where they will resume the initiation of translation. This local 
translational regulatory model provides a mechanism that meets the requirement for both 
increased and decreased protein synthesis (Saugstad, 2010).  
A small number of miRNAs involved in synaptic morphogenesis and plasticity have been 
identified through recent functional analysis. miR-138 is localized in dendrites of rat 
hippocampal neurons and it inhibits dendrite spine growth through activating the Rho signaling 
pathway. miR-138 targets acyl protein thioesterase 1 (APT1), which in turn catalyze membrane 
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association of Gα12/13. The membrane association of small G protein subunit Gα13 has been 
shown to be involved in the activation of RhoA signaling pathway (Siegel et al., 2009). In 
contrary, miR-132 expression enhances dendrite morphogenesis in hippocampal neurons. miR-
132 represses the expression of the Rho GTPase –activating protein (GAP) p250. p250GAP 
regulates spine formation through modulating Rac1 and RhoA activities. Therefore, miR-132 
expression is conversely related to P250GAP.  Introduction of miR-132 showed the same effect 
on dendritic spine phenotype as p250GAP knockout, which results in increased spine density and 
spine size (Olde Loohuis et al., 2012).  miR-134 is an example for neurotrophic control of 
dendritic spine plasticity through miRNA mechanism. miR-134 localized to dendrites negatively 
regulate the size of dendritic spine by inhibiting the expression of LIM domain kinase 1 (Limk1), 
neurogenic differentiation factor 2 (NeuroD2), and disks large homolog2 (DLG2). Exposure to 
brain-derived neurotrophic factor relieves the inhibition in spine development by miR-134, and 
increases the expression of Limk1 protein. Limk1 regulates actin filament dynamics, thereby 
controlling cytoskeletal reorganization, promoting spine outgrowth (Schratt et al., 2006). The 
involvement of miRNAs in synaptic plasticity is further confirmed with the changes of miRNA 
expressions after long-term potentiation. 
Compared with the studies in dendritic miRNAs, there is less understanding in the role of 
miRNA in axonal functions. However, the studies in axonal miRNA pathway are growing. Pure 
axonal miRNAs have been obtained from superior cervical ganglia neurons cultured in 
compartmentalized Campenot cell culture chambers. Totally, 130 matured miRNAs have been 
detected in distal axon, and a few miRNAs, including miR-15b, miR-16, and miR-221, are 
highly enriched in axons (Natera-Naranjo et al., 2010). miRNA machinery components, such as 
Dicer, argonaute proteins, fragile-X mental retardation protein (FMRP) have been found to be 
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localized in developing axons and growth cones in RNA granule-like structure (Hengst et al., 
2006). Although direct evidence for miRNA-mediated suppression of axonal mRNA translation 
has not been demonstrated, the involvement of the miRNA pathway in the regulation of axonal 
function is suggested by the functional activity of miRNA machinery in axons (Hengst et al., 
2006).  
Studies from our laboratory have shown that sciatic nerve axons contain functional 
miRNA biogenesis proteins (Murashov et al., 2007). They are functional when exogenous 
siRNAs are applied. Based on the fact the siRNA pathway and miRNA pathway share the same 
important functional enzymes, we presume that endogenous miRNAs may regulate translation in 
peripheral nerve axon and might play a role in regenerative axon growth during peripheral nerve 
regeneration.  
Objective of Current Study 
In the current study, we investigated the involvement of miRNA pathway in regulation of 
gene expression after sciatic nerve injury. To prove our hypothesis that miRNA pathway plays a 
critical role in peripheral nerve regeneration, the following three specific aims were devised: 
(1) Determine the expression of the miRNA biosynthetic machinery and miRNAs in 
regulation of response to nerve injury. We hypothesized that there will be injury-
regulated expression of miRNA biosynthetic enzymes, including components of RISC 
and P-body, and injury regulated expression of miRNAs 
(2) Determine the role of Dicer-dependent miRNA pathway in regulation of regenerative 
nerve growth. We hypothesized that the deletion of Dicer will disrupt production of 
Dicer-dependent small RNAs and will negatively impact peripheral nerve regeneration. 
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(3) Determine the specific miRNAs involved in regenerative axonogenesis. We hypothesized 
that some of the miRNAs may be the key regulatory switches for peripheral axonal 
regeneration. 
  
CHAPTER II: Methods 
Animals and Surgeries 
Animals 
The animal use protocol was approved by the institutional Animal Care and Use 
Committee of East Carolina University, an AAALAC-accredited facility. Animals were housed 
individually under standard laboratory conditions, with a 12 h light/dark schedule and unlimited 
access to food and water. In the approved animal use protocol, we included a detailed description 
of the research being conducted, minimized the number of animals being used in the study, 
minimized pain and distress to animals in the study, and proved there is no an alternative model 
to the use of a living animal. 
CD-1 mice: 8-wk-old CD-1 mice were obtained from Charles River laboratories 
(Wilmington, MA). 
Dicer mice: Breeding pairs of CAG-CreERt and Dicer
fl/fl 
mice were provided by Dr. 
Tatsuya Kobayashi as a generous gift (Kobayashi et al., 2008). The offspring, CAG-
CreERt:Dicer
fl/fl 
mice carried an homozygous allele of floxed Dicer gene (Dicer
fl/fl
) and 
heterozygous Cre gene with an inducible estrogen promoter. By breeding CAG-CreERt:Dicer
fl/fl 




littermates. Genotypes were 
determined by PCR using genomic DNA derived from tail biopsies. 
To induce the deletion of Dicer, 8-wk-old CAG-CreERt:Dicer
fl/fl 
mice received 
intraperitoneal (i.p.) injections of tamoxifen  (Sigma, St. Louis, MO) at the dose of 0.1mg/g body 
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weight for five consecutive days (Kobayashi et al., 2008). These animals were hereafter called 
Dicer KO (Dicer KO) mice in this study. Sesame oil (Sigma) with ethanol (EMD Chemicals Inc., 
Gibbstown, NJ) (3.75%) solution was used as vehicle to dissolve tamoxifen. CAG-
CreERt:Dicer
fl/fl
 mice with vehicle treatment (hereafter called vehicle treated group) and Dicer
fl/fl
 
littermates with tamoxifen treatment (hereafter called no-Cre group) were used as controls in this 
study (Fig 2.1.). All animals were normal at birth, exhibiting normal weight and weaning 
behavior as compared with control littermates. At 8 weeks, (beginning of tamoxifen treatment) 
heterozygous mutant mice were viable, normal in size, and did not display any physical or 
behavioral abnormalities. 
Conditioning nerve lesion 
Before surgery, anesthesia was induced using intraperitoneal Ketamine (18/mg/ml)-
Xylazine (2 mg/ml) mixture (0.05 ml/10 g of body weight, i.p). The procedure followed a 
protocol described previously (Islamov et al., 2004). Exposure of the right sciatic nerve was 
performed with sterile surgical instruments through an incision on the middle thigh of the right 
hind limb. Approximately 5 mm of nerve was exposed from the sciatic notch to the trifurcation 
of the nerve. The exposed sciatic nerve was crushed in the mid-thigh for 15 sec with a fine 
hemostat. The wounds were closed with 3M™ Vetbond™ Tissue Adhesive (3M, St. Paul, MN) 
and the recovery of sciatic nerve was monitored until the day we euthanized animals. 
 In the following experiments, the injured ipsilateral nerves were called injured nerves 
and the ipsilateral DRGs were called injured DRGs. The contralateral nerves were called naïve 
nerves and DRGs from contralateral side were called naïve DRGs. Nerves and DRG from intact 
animals were called intact nerves and intact DRGs.  
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Figure 2.1 Inducible Dicer knock out models. 
3 groups of animals were generated for the studies in specific aim 2. CAG-CreERt:Dicer
fl/fl 
mice 
received intraperitoneal (i.p.) injections of tamoxifen at the dose of 0.1mg/g body weight for five 
consecutive days were called Dicer KO (Dicer KO) mice in this study. Tamoxifen treatment 
induced Cre activation and results in the deletion of Dicer. Sesame oil solution was used as 
vehicle to dissolve tamoxifen. CAG-CreERt:Dicer
fl/fl
 mice with vehicle treatment were called 
vehicle treated group. Cre was not activated in this group and Dicer was normally expressed. 
Dicer
fl/fl
 littermates with tamoxifen treatment were used as another control in this study. Since 
this group did not carry Cre gene, treatment of tamoxifen could not induce the deletion of Cre, 










After specified time periods, animals were euthanized by exposure to isofluorane 
(Webster Veterinary, Devens, MA). Sciatic nerves were quickly dissected out, snap frozen in 
liquid nitrogen and stored at -80ºC for molecular analyses. The naïve nerve was taken from the 
contralateral side (sciatic nerve from left side). The excised crush sample was taken from the 
injury side approximately 5 mm in both directions from the point of injury. The intact nerve 
sample was taken from mice at the matched age without sciatic nerve crush surgery. Ipsilateral 
and contralateral L4-L5 DRGs were collected under dissecting microscope for RNA and protein 
analyses. 
X-gal staining of Sciatic Nerves 
For Dicer mice, 5 days after tamoxifen or vehicle treatment, 5 mice were randomly 
selected from each group, and around 1 cm of sciatic nerve was dissected from 3 groups of mice. 
Sciatic nerves were first fixed in 0.5% glutaraldehyde in PBS with Magnesium Chloride (2mM) 
on ice for 30 minutes, and then rinsed in 3 changes of PBS. X-gal stock (Sigma) was diluted into 
X-gal reaction buffer and was incubated with the tissue for 2-4 hours at 37° C.  The sciatic 
nerves were rinsed in PBS until the solution ran clear. The activity of β-galactosidase was 




Analyses of Functional Recovery  
Functional motor recovery 
Functional recovery of motor function after sciatic nerve crush was analyzed using a 
walking track assessment, and quantified with the sciatic functional index (SFI). Paw prints were 
recorded by painting the hind paws with black ink and having the animals walk along an 8x40 
cm corridor lined with a white paper. The toe spread and the paw length were measured from 
those prints to calculate SFI (McMurray et al., 2003). The resulting SFI was calculated according 
to the formula described as:  
SFI=118.9 (ETS – NTS)/NTS – 51.2(EPL – NPL)/NPL-7.5 
where ETS represented experimental toe spread, NTS represented normal toe spread, EPL 
represented experimental paw length, and NPL represented normal paw length. The value of SFI 
ranges from -100 to 0. A SFI close to zero suggests normal nerve function or completely 
recovery of nerve function, and a value of 100 indicates total loss of function. The walking 
corridor analysis was performed on animals before crush injury as baseline tests, and at 2, 4, 7, 
14, and 21 days after injury. 
Mechanical sensitivity test 
Mechanical sensitivity (allodynia) was studied with the von Frey test. Filaments with 
stimulus intensities ranging from 0.08-10 grams were applied to the glabrous skin of each hind 
paw eight times while the animal stood on an elevated screen. Before testing, a 15 min quiescent 
period was allowed. Filaments were applied to the point of bending, at which time substantiation 
of response or non-response was determined. Responses included hind paw withdrawal and 
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orientation toward the stimulus. During each test session, the filament that produced a threshold 
response (response to over 4 out of 8 stimuli) in each animal was documented for both the left 
and right hind paws (Okada et al., 2002). Raw data measurements were recorded as stimulus 
intensities required to elicit a threshold response and subsequently normalized to baseline values. 
Electrophysiological analyses on isolated sciatic nerves 
Electrophysiological approaches were used to assess the effects of Dicer deletion on 
nerve conduction velocity (NCV) and compound action potential (CAP) amplitude of the 
regenerating sciatic nerve, at 14 and 21 d after injury. Mice were euthanized by decapitation 
under deep anesthesia with ketamine (18 mg/ml)-xylazine (2 mg/ml), and sciatic nerves from 
injured and contralateral uninjured side were dissected from the ankle to the spinal column at a 
length of ~ 20 mm and immediately placed in Locke solution (154 mM NaCl, 5.6 mM KCl, 2.2 
mM CaCl2, 5 mM dextrose, 2 mM HEPES, pH 7.2), equilibrated to room temperature. Nerve 
segments were straightened and fixed in a slightly stretched position by pinning the two ends to 
the bottom of a Sylgard-lined dissecting dish. After removing all connective tissues from the 
nerves, glass suction electrodes were gently attached to the nerves, proximal and distal to the site 
of the injury, usually ~ 2 cm apart and bracketing the injury site by ~ 1cm. The proximal site was 
stimulated with a series of 10 constant-current pulses of 500 µA and 100 µs, at intervals of 2 s, to 
achieve a maximal and stable peak CAP response recorded at the distal side. To minimize the 
size of the stimulus artifact and maximize the size of the CAP signal, the diameters of the suction 
electrode were fabricated to match the diameter of the sciatic nerve. Signals were recorded, 
amplified with a 4-channel extracellular amplifier (AM Systems, Model 1700, Sequim, WA), 
and digitized with a Digidata 1322A using pClamp 10 software (both: Molecular Devices, 
Sunnyvale, CA, USA). Data were subsequently analyzed off-line with pClamp and SigmaPlot 
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(Version 11, Systat, San Jose, CA) software. In short, signal responses from injured nerves were 
rectified and the calculated integrals of these responses were measured against control epochs of 
identical duration from intact controls. Comparisons were made between the averaged 
amplitudes of ten consecutive responses measured between injured and un-injured sides at each 
time point. 
Histological Evaluation of Re-myelinated Axons 
Semi-thin sections of sciatic nerves were prepared to visualize the re-myelinated axons. 
The lesioned portions of the sciatic nerves were fixed with cold 2.5% glutaraldehyde, post-fixed 
with 1% osmium tetraoxide solution, dehydrated stepwise in increasing concentrations of 
ethanol, embedded with Low Viscosity Embedding Media Spurr's Kit (EMS, Hatfield, PA), and 
cut into transverse sections. Transverse semi-thin sections (1 μm thick) were stained with 
Richardson's solution. The number of myelinated axons was counted under bright field 
microscope at magnification of 40X. The myelinated axon area was quantified at 40X 
magnification using the NIH ImageJ software package, as described previously (McMurray et 
al., 2003). 
Cell Cultures and Transfection 
Dissociated DRG cultures 
Mouse L4/5 dorsal root ganglion (DRG) neurons were collected 5 days after a 
conditioning sciatic nerve crush from both the intact side and injured side. DRGs were 
dissociated with collagenase and 0.25% trypsin in Dulbecco’s modified Eagle’s medium 
(DMEM) (GIBCO, Carlsbad, CA). The dissociated DRGs were plated on Poly-L-Lysine and 
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Laminin (Invitrogen, Carlsbad, CA), coated plates. DRGs were grown in DMEM/F12 containing 
10% horse serum, L-glutamine and N2 supplement (Gemini Bio-product, West Sacramento, CA) 
at 37º C for 18hrs. To inhibit glial cell growth Cytosin β-D-arabinofuranoside (Arac, 10 µM) and 
5,6-dichlorobenzimidazole riboside (DRB, 80 μM) (Sigma, Saint Louis, Missouri) or 50 nM 5-
Fluoro-2’-deoxyuridine (Sigma) were added in the growth medium.  
Administration of 4-hydroxytamixifen in cell cultures 
To induce Cre-mediate Dicer knockout in neuronal cell cultures instead of in whole 




 mice without any 
treatments. DRG neuronal cells were dissociated and plated as describe previously. 4-
hydroxytamoxifen (Sigma-Aldrich, St Louis, MO, USA) was dissolved in DMSO with 
sonication to obtain 1 µM stock solution and applied to DRG cultures in a final concentration of 
1 nM. DRGs collected from Dicer
fl/fl
 mice were cultured with either 4-hydroxytamoxifen or 
DMSO, corresponding to no-Cre group and vehicle treated group in other studies. DRG neurons 
collected from CAG-CreERt:Dicer
fl/fl 
mice with 4-hydroxytamoxifen in culture media 
corresponded to Dicer knockout group.  
PC12 cell cultures 
PC12 cells were cultured in Dulbeccos’ modified Eagle’s medium (DMEM) containing 
10% horse serum, 5% fetal bovine serum 2mM glutamine, and penicillin and streptomycin 
(100unitl/ml).  The cells were plated on collagen-coated cell culture dishes. For NGF-induced 
differentiation of PC12 cells, NGF (50 ng/ml) was added to cell culture medium to initiate 
neurite outgrowth. Medium was refreshed every 2-3 days.  
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Transfection of miRNA mimics and inhibitors 
In order to determine the biological effects of each individual miRNA on regenerative 
axon growth, we performed functional analyses for injured induced miRNAs. Gain-of-function 
experiments were performed with Ambion® Pre-miR™ miRNA Precursor Molecules, which are 
also called miRNA mimics. With transfection reagent, these small, chemically modified double-
stranded RNA molecules can be introduced into cells and be taken up into the RNA-induced 
silencing complex, mimicking endogenous mature miRNAs activity. Loss of function analyses 
were performed with Ambion® Anti-miR™ miRNA Inhibitors. The miRNA inhibitors are 
chemically modified, single stranded nucleic acids designed to specifically bind to 
complementary miRNAs. The bindings between endogenous miRNA and miRNA inhibitors 
down-regulate endogenous miRNAs activity. 
miRNA precursors and miRNA inhibitors were obtained from Ambion (Austin, TX). 
Transient transfections of DRGs were performed using Lipofectamine™ LTX and Plus Reagent 
(Invitrogen, Grand Island, NY) according to the manufacturer's protocol. To extend the time 
window for effective transfection of miRNA precursors and inhibitors, as well as, initiation of 
miRNA machinery, we incubated DRG neurons with 20 µM of SP600125 for the first 24 hours. 
SP600125 is a specific inhibitor of JNK and reversibly inhibits axonogenesis (Davare et al., 
2009). We then released the block on axonogenesis from the SP600125 by washing out 
SP600125 and change culture media. DRG neurons were then cultured for an additional 24 hours 




Immunofluorescent Staining and Image Analysis 
After culturing lumbar DRGs on coverslips overnight, the cells were fixed with 4% 
paraformaldehyde for 5 min and washed with PBST. After blocking with 10% goat serum for 1 
hour at room temperature, the samples were incubated with the indicated primary antibodies 
diluted at optimized concentrations at 4º C overnight. This was followed by incubation with 
secondary antibodies conjugated with FITC- , TX Red-, AMCA- or Alexa Fluor® (Invitrogen). 
Negative controls included samples processed in parallel with nonimmune serum or without 
primary antibodies. After mounting the slides with antifading media (Invitrogen), images were 
viewed with an Olympus IMT-2 fluorescent microscope and recorded using the Spot digital 
camera system (Diagnostic Instruments, Sterling Heights, MI), or viewed and captured with 
Leica DMI6000 B Imaging System powered by MetaMorph, or viewed with an Olympus IX81 
fluorescent microscope and captured with CellSens Dimension software. The images we 
acquired were all single plane fluorescent images. For high magnification images and Z-stacks, 
images were taken with Olympus FluoView™ FV1000 confocal microscope at UNC 
Neuroscience Center (Chapel Hill, NC, USA).  
Quantification of axon length and measurement of axon branches were performed 
following previously described lab protocol (Murashov et al., 2005). For each coverslip, 30 
images were taken, and from each, 10-15 neurons, which were completely distinguishable from 
neighboring cells, were chosen for further analysis. The axon length was quantified by tracing 
the image of neurites with the ImageJ software. The longest axon for each neuron was measured 
and recorded. The number of neurite branches per neuron was also determined from each 
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neuronal population manually. Only branches longer than one cell body in length were counted 
(Liu et al., 2002). 
Protein Lysates 
Proteins were extracted from the sciatic nerves collected at specific time points. To obtain 
adequate proteins for these experiments, at least 5 animals were pooled per time-point. Samples 
of sciatic nerves were homogenized in ice-cold homogenization buffer, containing protease 
inhibitor cocktail (Sigma, St. Louis, MO), 1 mM PMSF, 20 mM Tris, 2 mM EGTA, 2 mM 
EDTA, 6 mM ß-mercaptoethanol and 10% Triton and centrifuged at 10,000g  for 10 min at 4º C. 
The supernatant was transferred to a fresh tube and stored at -20º C until ready for use. 
Immunoblotting Analysis 
Tissue samples were homogenized in ice-cold homogenization buffer (20 mM Tris, 2 
mM EGTA, 2 mM EDTA, 6 mM β-mercaptoethanol, 1 mM PMSF, and 10% Triton) containing 
protease inhibitor cocktail (Sigma, St. Louis, MO), and centrifuged at 10,000 g for 10 min at     
4° C. The supernatants were collected in fresh tubes and stored at -20 °C. Proteins concentrations 
were quantified using the BioRad reagent (BioRad, Hercules, CA) and samples for western blot 
analysis were prepared by boiling with standard stop buffer for 5 min. Equal amounts of 
solubilized proteins were loaded per lane on sodium dodecyl sulfate gels and separated by 
electrophoresis. The separated proteins were then transferred to immobilon P membranes 
(Millipore Corporation; Bedford, MA).  
Two types of secondary antibodies were used. When experiments were performed with 
horseradish peroxidase (HRP) conjugated secondary antibodies, membranes were blocked in 5% 
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non-fat milk/PBST for 1 hr at room temperature on a shaker, and then probed with primary 
antibody against FMRP (Darnell et al., 2005), Ago2 (Ikeda et al., 2006), P-100 (Keenan et al., 
2000), DCP-1 (Lykke-Andersen, 2002) (Abnova; Walnut, CA), DCP-2 (Lykke-Andersen, 2002, 
Wang et al., 2002b), Rap55 (Yang et al., 2006), Ro52 and GWB IC-6 (Pauley et al., 2006) in 5% 
non-fat milk/PBST at 4º C overnight. For negative control groups, membranes were incubated 
with pre-immune serum. The membranes were washed three times with TBS, and then incubated 
with secondary antibody in 5% milk/PBST for two hours at room temperature. After incubation 
with horseradish peroxidase (HRP) conjugated secondary antibodies, bound antibodies were 
detected using a chemiluminescence detection system (ECL plus Western blotting detection 
reagent, Amersham; Arlington Heights, IL, USA). Densitometry was performed using Kodak 1D 
Image Analysis software.  
When infrared dye (IRDye
®
) conjugated secondary antibodies were used, membranes 
were blocked in Odyssey blocking buffer (LI-COR, Nebraska, USA) for 1 hour at room 
temperature on a shaker, and then probed with primary antibody against Dicer (Abcam, MA, 
USA) at 4° C overnight. After washing, membranes were incubated in IRDye
®
 conjugated 
secondary antibodies for one hour at room temperature with gentle shaking. The fluorescence 
signals on membrane were detected with the Odyssey® Infrared Imaging System (LI-COR). 
Band
 
values were normalized to alpha-tubulin, to obtain the relative signal intensity. One-
way ANOVA were performed on injured, naive versus intact relative densitometric intensity
 
for 




List of Antibodies 
Primary antibodies 
Rabbit polyclonal anti-AGO2- specific antibody (Tom Hobman, University of Alberta, Canada)  
Guinea pig polyclonal anti-P100 antibody (Tom Keenan, VA Polytechnic Institute and State 
University, Blacksburg, VA) 
Rabbit polyclonal primary antibody against DCP-1, DCP-2 (Jens Lykke-Anderson, University of 
Colorado, Colorado) 
Rabbit polyclonal anti-DCP2 primary antibody (M. Kilejian, Rutgers University, New Jersey) 
Human anti-Rap55 antibody (Donald Bloch, Harvard University, MA) 
Antibody against GWB IC6 (Marvin Fritzler, University of Calgary, Alberta, Canada) 
The specificities of the antibodies, provided by individual investigators, have been validated by 
original research groups and the corresponding data have been published elsewhere. 
Mouse Anti-Human DCP1A Monoclonal Antibody from Abnova (Walnut, CA) 
Rabbit anti-Ro52 polyclonal antibody from Millipore Corporation (Bedford, MA)  
Mouse monoclonal neuro-specific beta III tubulin antibody (TUJ-1) from Covance Research 
Products, Inc. (Denver, PA) 
Mouse monoclonal anti-FMRP antibody was purchased from Developmental Studies Hybridoma 
Bank (Iowa City, Iowa). 
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Rabbit polyclonal antibodies against Dicer (Abcam, MA, USA)  
Goat polyclonal antibodies against Kremen1 (R&D Systems, Minneapolis, MN)  
Rabbit anti-GAP-43 polyclonal antibodies (Millipore, Billerica, MA)  
Mouse monoclonal anti-α-Tubulin antibodies from ZYMED (ZYMED laboratories, Carlsbad, 
CA)  
Secondary antibodies 
HRP conjugated anti-rabbit IgG and HRP conjugated anti-mouse IgG from R&D system 
(Minneapolis, MN).  
IRDye 800CW goat anti-Mouse IgG, IRDye 680LT goat anti-Rabbit IgG, and IRDye 800CW 
donkey anti-goat IgG secondary antibodies, (LI-COR Corporate, Nebraska USA). 
For fluorescence studies, secondary FITC-, TX Red-, Cy-3, or Cy5-conjugated IgG (Jackson 
ImmunoResearch Laboratories, Inc; West Grove, PA) or Alexa Fluor 350 donkey anti-mouse 
IgG, Alexa Fluor 594 goat anti-human IgG, Alexa Fluor 594 donkey anti-goat from Invitrogen 
(Eugene, Oregon, USA) were applied.  
Microarray Analyses 
miRNA microarray analyses for sciatic nerve RNA 
Total RNA for the microarray expression analysis was isolated from sciatic nerves, 
pooled from 10 mice, at 4 and 7 days after the sciatic nerve crush. 5 micrograms of total RNA 
were labeled with RNA ligase and a Cy3-conjugated dinucleotide, and hybridized to custom 
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oligonucleotide microarrays as described previously. Cy3 median intensity values were filtered 
to remove data points that did not exceed background levels by two fold. Values were log2-
transfomed and median centered by array. Clustering was performed with Cluster (Stanford 
University, CA, USA), using values that were median-centered by gene. Dendrograms and 
expression maps were generated using Treeview (Stanford). Some pooled samples were sent to 
UNC Lineberger Comprehensive Cancer Center Genomics Core. After a quality check, they 
were hybridized to an 8x15K miRNA one color arrays (Agilent, Santa Clara, CA, USA). Both 
custom and Agilent arrays were done in duplicates and repeated two times. Normalization and 
analyses were performed with GeneSpring software (Agilent). The GeneSpring analysis software 
was used for the identification of statistically significant upregulated or downregulated miRNAs 
at selected time points. The analysis also allowed for identification of a different temporal 
pattern of expression in the crushed groups compared with the control groups at the chosen 
points. For further analyses, we selected three miRNAs that were significantly upregulated and 
on that was significantly downregulated in both custom array as well as Agilent arrays.  
miRNA and gene expression array analyses for DRG RNA 
Total RNA for the microarray expression analysis was isolated from L4-L5 DRGs, 
pooled from 10 mice at 4 days after sciatic nerve crush. Total RNA extraction was performed 
with miRVANA
TM
 miRNA isolation kit following the manufacturer’s instruction (Ambion). 
These pooled RNA samples were sent to UNC Lineberger Comprehensive Cancer Center 
Genomics Core for microarray analysis. After a quality control, they were hybridized to an 8x15 
miRNA one color arrays (Agilent, Santa Clara, CA, USA). The same RNA samples were also 
hybridized to 4x44K mouse gene expression microarrays (Agilent) at the same Genomics Core. 
All microarray experiments were performed in duplicate and repeated twice. Normalization and 
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further analyses of microarray data were performed with GeneSpring software (Agilent). The 
analysis with GeneSpring allowed for identification of a different expression pattern of miRNAs 
in the crushed groups compared with the control groups. Statistically significant upregulated or 
downregulated miRNAs were then selected for further analysis. 
Real-time RT-PCR 
Total RNA was isolated from pooled sciatic nerves (n=6) for each group at each time 
points or from L4-L5 DRGs using mirVana
TM
 miRNA Isolation Kit (Ambion, Austin, TX). Total 
RNAs from DRG neuronal cell cultures was purified with RNAqueous Micro Scale RNA 
Isolation Kit (Ambion, Austin, Texas, USA). RNA was quantified with a NanoDrop ND-1000 





 miRNA cDNA Synthesis Kit and SuperScript VILO cDNA Synthesis 
Kit (Invitrogen, Life Technologies, Town, CA) for miRNA expression analysis and mRNA 
expression analysis respectively. The real-time PCR reactions were carried out using EXPRESS 
SYBER
®
 GreenER™ qPCR SuperMix Universal (Invitrogen) in triplicates for each cDNA 
sample on Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, Life 
Technologies, Carlsbad, CA). Primers specific for each miRNA and mRNA were obtained from 
Invitrogen (Grand Island, NY). As an internal control, primers for S12 were added for RNA 
template normalization, and the relative quantification of gene and miRNA expressions were 
calculated against S12 using a 2
-∆∆CT
 method. All experiments were carried out three times 
independently.  
List of primers 
miR124a: 5’-TAAGGCACGCGGTGAATGCC-3’  
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Dicer: 5’-AGTGTAGCCTTAGCCATTTGC-3’ and 5’-CTGGTGGCTTGAGGACAAGAC-3’  
Kremen1: 5’-ACAGCCAACGGTGCAGATTAC-3’ and 5’-TGTTGTACGGATGCTGGAAAG-
3’ 
GAP-43: 5’TGGTGTCAAGCCGGAAGATAA-3’ and 5’-GCTGGTGCATCACCCTTCT-3’ 
PTK-9: 5’-AATGAGCAACTGGTGGTTGG-3’ and 5’-GGGCATTCTGAGAGTCTAACCT-3’ 
S-12: 5-’TGGCCCGGCCTTCTTTATG-3’ and 5’-CCTAAGCGGTGCATCTGGTT-3’ 




Bioinformatic Prediction and Selection of Target Genes  
Prediction for miR-431 target genes were conducted by 2 web-based miRNA target 
prediction programs: Targetscan (www.targetscan.org) and microRNA.org (www.microrna.org). 
Potential targets were chosen from genes predicted by both program, and the list of genes was 
compared with gene expression profile from gene expression array.  
Since miR-431 was overexpressed in DRG after sciatic nerve injury, the expression of its 
target genes should be suppressed after injury. Therefore, selected genes had to meet the 
following criteria for the experimental analysis (Fig 2.2). First, they had to have a potential 
complementary binding site for miR-431 in their 3’UTR, as predicted by bioinformatics 
algorithms. Second, their expression level had to be downregulated in DRG after sciatic nerve 
crush in our gene expression array analysis. The changes in the expression of selected potential 





Figure 2.2. Selecting of potential target genes for miR-431 
The list of genes with potential binding sites for miR-431 at their 3’ UTR were generated by 2 
web-based miRNA target prediction programs: Targetscan (www.targetscan.org) and 
microRNA.org (www.microrna.org). The list of genes significantly downregulated in DRG with 
overexpression of miR-431 after sciatic nerve injury was generated by gene expression array 
analyses. 24 genes that were on both lists were selected as potential target genes for further 
experimental validation. 
miR-431 was first overexpressed transiently with miR-431 mimic in neuronal cells derived from 
PC12 cells. 8 out of 24 potential target genes showed downregulated expression. We further 
tested the expression of these 8 genes in DRG neuronal cell cultures with overexpression of miR-
431. The 3 downregulated genes were selected for the following cross-linked 








In Situ Hybridization 
Similar to the immunofluorescence protocol described above, dissociated DRG cultures 
were postfixed in 4% paraformaldehyde solution in PBS at room temperature for 5 min, washed 
in PBS twice for 5 min and incubated in 100% methanol + 0.3% hydrogen peroxide solution for 
10 min at 4° C. After two washes in PBS for 10 min, cell cultures were prehybridized at 42°C for 
1 hour in hybridization buffer, containing 600 mM sodium chloride, 50mM sodium phosphate 
buffer (PH 7.0), 5.0 mM EDTA, 0.02% Ficoll (Sigma), 0.02% BSA (Sigma), 0.02% 
polyvinylpyrrolidone (Sigma), 200ng/ml sheared and denatured salmon sperm DNA (Sigma), 
and 40% formamide (Fisher Scientific, Pittsburgh, PA, USA). Hybridization was performed at 
42° C in the same buffer with the addition of dextran sulfate to 7%, tRNA(baker’s yeast) to 0.1 
mg/ml, poly-A to 10µg/ml, and LNA antisense or sense oligonucleotide probes against miR-21, 
miR-142-5p and U6 to a final concentration of 1 ng/µl. Mir-21 FITC –labeled LNA antisense 
and sense probes were obtained from RiboTask (Odense, Denmark). Mir-142-5p FITC –labeled 
LNA antisense and scrambled probes, and a U6 LNA probe were obtained from Exiqon 
(Woburn, MA).  After hybridization coverslips were incubated for 1 hour with primary 
antibodies against FITC, neuronal β-tubulin and GWB.  To visualize the signal, FITC-, TX Red-, 
and AMCA- labeled secondary antibodies (Invitrogen) were applied for 1 hour in 1:100 dilution.  
Slides were viewed on an Olympus IMT-2 fluorescent microscope.  
Cross-Linked Immunoprecipitation Analysis 
DRG neuronal cell cultures were transfected with 100 nM of miR-431 mimic or a 
scrambled miRNA mimic negative control. Two days post-transfection, the cells were rinsed 





 and once more for 200 mJ/cm
2
 to establish protein-RNA reversible crosslinking. Cell 
were lysed in cell lysis buffer (100 mM KCL, 5 mM MgCl2, 10 mM HEPEs, PH 7.0, 0.5% NP-
40, 1 mM DTT, 100 U/ml RNasin RNase inhibitor (Promega), 2 mM vanadyl ribonucleoside 
complexes solution (Sigma),) supplemented with a mixture of protease inhibitors (Invitrogen, 
Grand Island, NY). Cells were then detached with a cell scraper and lysate was transferred to a 
tube on ice. Cell lysates were centrifuged at 16,000g for 15 min at 4º C. Prior to the 
immunoprecipitation, protein G agarose beads (Sigma, St. Louis, MO) were equilibrated by 
washing twice with a wash buffer (0.5% NP-40, 150 mM NaCl, 2 mM MgCl2, 2 mM Cacl2, 20 
mM Tris, pH. 7.5, 5 mM DTT, with protease inhibitor) containing 1 mg/mL yeast tRNA and 
1mg/mL BSA. After pre-clearing the lysate with equilibrated protein G-agarose beads, 5 μl of 
each sample was saved as an input fraction. The protein lysate was immunoprecipitated with 
specific mouse monoclonal antibodies against Ago2 (Wako, Richmond, VA) or control serum 
and bounded by protein G agarose beads with agitation at 4° C overnight. After precipitation, the 
beads were washed 3 times with washing buffer. Afterwards, the bonds between RNA and 
protein were disrupted by heating at 50° C for 30 minutes. RNA was then extracted and purified 
using Trizol (Invitrogen). 
 
Statistical Analysis 
Data from multiple independent experiments were analyzed with GraphPad Prism version 
5 for Windows (GraphPad Software; San Diego, CA, USA). The results were expressed as mean 
± standard error of the mean in graphic and text representations. For comparing injured groups, 
naïve group, and intact group, statistical analysis was performed with one-way ANOVA and 
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Newman-Keuls Multiple Comparison Test using Prism (GraphPad Prism version 3.00 for 
Windows, GraphPad Software; San Diego, CA, USA). The difference between 3 groups (CAG-
CreERt:Dicer
fl/fl
 mice with tamoxifen treatment, CAG-CreERt:Dicer
fl/fl
 mice with vehicle 
treatment, and Dicer
fl/fl
 littermates with tamoxifen treatment) at each time point were evaluated 
with one-way ANOVA followed by Bonferroni’s multiple comparison test using GraphPad 
Prism version 5 for Windows (GraphPad Software; San Diego, CA, USA). In the last specific 
aim, to determine the difference between three or more groups, one-way ANOVA followed by 
Bonferroni’s multiple comparison tests was utilized. For the analysis of two independent groups, 
student’s t-test was used. A p-value of less than 0.05 was considered statistically significant. 
  
CHAPTER III: MicroRNA Machinery Responds to Peripheral 
Nerve Lesion in an Injury-regulated Pattern. 
Summary 
Recently, functional and potent RNA interference (RNAi) has been reported in peripheral 
nerve axons transfected with short-interfering RNA (siRNA). In addition, components of RNA-
induced silencing complex (RISC) have been identified in axotomized sciatic nerve fibers as 
well as in regenerating dorsal root ganglia (DRG) neurons in vitro. Based on these observations, 
and on the fact that siRNA and microRNAs (miRNA) share the same effector enzymes, we 
hypothesized that the endogenous miRNA biosynthetic pathway would respond to peripheral 
nerve injury. To answer this question, we investigated changes in the expression of miRNA 
biosynthetic enzymes following peripheral nerve crush injury in mice. Here we show that several 
pivotal miRNA biosynthetic enzymes are expressed in an injury-regulated pattern in sciatic nerve 
in vivo, and in DRG axons in vitro. Moreover, the sciatic nerve lesion induced expression of 
mRNA-processing bodies (P-bodies), which are the local foci of mRNA degradation in DRG 
axons.  In addition, a group of injury-regulated miRNAs was identified by miRNA microarray 
and validated by qPCR and in situ hybridization analyses. Taken together, our data support the 





One of the unique features of the peripheral nervous system (PNS) is its ability to 
regenerate axons after injury (Yoo et al., 2009). To initiate a regenerative response, the PNS 
neuron must shift its physiology from synaptic transmission and maintenance of structure to the 
growth of the axon (Benowitz and Yin, 2007). Shifting to the growth phenotype requires both 
activation of a growth program via gene transcription as well as activation of local signaling 
cascades that regulate axon assembly (Snider et al., 2002, Vogelaar et al., 2009). Recent 
observations suggest that the microRNA (miRNA) pathway may be involved in regulation of 
these processes (Hengst et al., 2006, Murashov et al., 2007).  
The miRNA pathway is an important layer of post-transcriptional gene regulation 
(Jackson et al., 2010). MiRNAs are initially processed in the nucleus by biosynthetic enzymes, 
Drosha and DGCR8/Pasha, while in cytoplasm Dicer cleaves them into the mature miRNAs 
(Bernstein et al., 2001, Lee et al., 2003). MiRNAs then trigger formation of RNA-induced 
silencing complex (RISC), which is implicated in a sequence-specific translational repression 
called RNA interference (RNAi) (Bagga et al., 2005, Tan et al., 2009). Several subunits of RISC 
have been conclusively identified to date: Argonaute2 (Ago2) nuclease (Hammond et al., 2001, 
Meister and Tuschl, 2004), fragile X mental retardation protein (FMRP) (Ishizuka et al., 2002),  
p100 (Caudy et al., 2003), TRBP (Chendrimada et al., 2005), PACT (Lee et al., 2006), and 
RCK/p54 (Chu and Rana, 2006). Recent studies showed that Argonaute proteins interact with the 
RNA-binding protein GW182 (Sen and Blau, 2005, Eulalio et al., 2009a, Eulalio et al., 2009b, 
Takimoto et al., 2009). Observations revealed that GW182-containing foci, known as GW bodies 
(GWBs), coincide with mRNA-processing bodies (P-bodies) where GW182 co-localizes with the 
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de-capping complex (Dcp1, Dcp2), Rap55 and Ro52 (Sen and Blau, 2005, Bhanji et al., 2007, 
Eulalio et al., 2009a, Eulalio et al., 2009b, Takimoto et al., 2009). Importantly, depleting GW182 
suppressed silencing of miRNA targets. Therefore, these observations suggest that in addition to 
RISC, target silencing by miRNAs is regulated by P-bodies.  
Recent studies revealed the differential expression of a number of miRNAs following 
traumatic injury in CNS, including the brain and spinal cord (Lei et al., 2009).  Reduction in the 
expression of several sensory organ-specific miRNAs was also observed in the injured ipsilateral 
dorsal root ganglion (DRG) following spinal nerve ligation (SNL) (Aldrich et al., 2009). These 
evidences suggest that miRNAs are likely to be important mediators of plasticity.  Functional 
RNAi machinery has been reported in axons of PNS neurons (Yoo et al., 2009). Components of 
RISC were observed in severed sciatic nerve fibers and cultured DRG axons (Hengst et al., 2006, 
Murashov et al., 2007). Based on these observations and on the fact that siRNA and miRNA 
share the same effector enzymes, it is logical to presume that the endogenous miRNAs 
machinery could be involved in the regulation of molecular response to peripheral nerve injury. 
In the current study, we asked whether miRNA might be one of the pathways that 
respond to peripheral nerve injury. Here we show an injury-regulated expression of several 
pivotal miRNA biosynthetic enzymes in murine sciatic nerve in vivo, and in DRG axons in vitro. 
In addition, a group of miRNAs, which were expressed in an injury-regulated pattern in 
regenerating sciatic nerve and DRG was identified by miRNA microarrays, qPCR and in situ 
hybridization.  These data provide further evidence in support of the hypothesis that the 





Levels of miRNA biosynthetic proteins in sciatic nerve are regulated by injury 
To investigate whether the expression of miRNA biosynthetic proteins was correlated 
with injury, we first determined the expression of protein components of RISC (FMRP, Ago2 
and P-100) and P-body (DCP-1, DCP-2, Rap55, Ro52 and GWB IC-6) at 4 and 7 days post-
crush. In a mouse, the process of nerve regeneration has been shown to be active over this 
period, justifying the time-points for these experiments (Garbay et al., 2000, McMurray et al., 
2003). Previous studies in our lab already showed the existence of the components of RISC in 
peripheral nerve axon in vivo and vitro (Murashov et al., 2007). Here we used immunoblot 
analyses to determine the injury-regulated expression of biosynthetic components of RISC and 
P-body. Immunoblot analysis revealed the expression of the components of these multiprotein 
complexes in response to injury, indicating the potential role of miRNA biosynthetic machinery 
in peripheral nerve regeneration. Figure 3.1 indicates that the expressions of the RISC 
components, including FMRP, Ago-2, and P-100 were induced in response to injury, when 
compared to intact nerve. The densitometry showed significantly elevated levels of Ago2, 
FMRP, and P-100 respectively at 4 days (Fig. 3.1A) and 7 days (Fig. 3.1B) after injury.  The 
contralateral naïve side of the nerve had the comparable expression level of RISC components as 
the intact nerve.  The results indicated the induction of RISC in sciatic nerve upon injury. In 
addition, the injury differentially affected levels of P-body proteins, another miRNA-associated 
multiprotein complex (Fig. 3.2). We observed upregulation of DCP-1 and GWB IC-6 at 4 days 
following sciatic nerves injury (Fig. 3.2 A) and downregulation of DCP-2 and Ro2 respectively, 
in response to 4 day post injury (Fig. 3.2 A).  In contrast, the expression of Rap55 was not 
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affected by the injury.  Therefore, the results indicated that injury to sciatic nerve selectively 
affected the expression of the P-body components.  
Components of miRNA machinery are differentially expressed in dissociated DRG neurons 
after injury 
In the previous experiments we showed that miRNA machinery was present and induced 
in peripheral nerve after injury.  In the next experiment we asked whether the source of the 
differentially expressed miRNA biogenesis enzymes might be of axonal origin. To answer this 
question, we performed immunofluorescence staining on murine dissociated DRG neurons to 
visualize the presence of P-body proteins in axons.  The DRG neurons plated at a low density 
were stained with FITC conjugated antibodies against DCP-1 (Fig. 3.3B) and Alexa 594-
conjugated antibodies against GWB IC-6 (Fig. 3.3C). The human polyclonal serum against 
GWB was used previously to detect P-bodies. Since the polyclonal antibodies could detect other 
proteins associated with GW182 protein in GWB, antibodies against DCP-1, another major 
component in P-bodies was used to further confirm the localization of P-bodies in axon. AMCA 
staining against TUJ1, a neuronal marker indicated the location of neuronal soma and axons (Fig. 
3.3A). Confocal immunofluorescence showed colocalization of GWB IC-6 with DCP-1 in the 
varicosities along axons (Fig. 3.3D). A Z-scanning showed a complete overlap of 
immunoreactivities against DCP-1 and GWB in axons.   
These results clearly demonstrated the colocalization of P-bodies proteins in the 
varicosities along axons. By comparing the images of DRG neurons collected from the injured 
side (Fig. 3.4A) and the DRG neurons collected from the naïve side (Fig. 3.4B), we revealed that 
preconditioning by crush injury not only induces more robust axon regenerative growth but also 
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induces the formation of P-bodies in regenerating axons. Quantifications of the mean number of 
the varicosities containing P-bodies per neuron in naïve versus regenerating DRG cultures 
revealed that the average number of varicosities containing P-bodies per neuron increased over 
~2.4 fold, from around 3 (n=30) to around 8 (n=30) following injury (Fig. 3.4 C). These findings 
were consistent with the Western Blot results, which indicated that the expression of miRNA 
biogenesis enzymes followed an injury-regulated pattern. 
MiRNAs and genes are expressed in an injury-regulated pattern after conditioning nerve 
lesion 
Since we observed an injury-regulated expression of miRNA biosynthetic enzymes after 
the sciatic nerve crush, we asked if the pattern of miRNA expression could be also injury-
regulated. Total RNA was isolated from pooled crushed and contralateral intact sciatic nerves 
and subjected to custom and Agilent miRNA expression arrays. Genespring analysis of array 
data revealed a set of differentially expressed miRNAs.  The miRNAs that were following 
injury-regulated expression pattern at both 4 and 7 days post-crush were selected for subsequent 
analyses. Three most high upregulated miRNAs, that is, miR-21, miR-142-5p, and miR-221 as 
well as brain-specific miR-124a, which was significantly downregulated were selected for 
further analyses (Table 1 and 2). 
qPCR confirms injury-regulated expression of miR-21, miR-142-5p, miR-221, and miR-
124a 
To verify the result of miRNA array, we next determined the expression of selected 
miRNAs in the same total RNA samples that were used for arrays. Real-time RT-PCR 
demonstrated the same pattern of expression of miR-124a, miR-221, miR-142-5p, and miR-21, 
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after sciatic nerve crush (Fig. 3.5). In agreement with the microarray data, the real time RT-PCR 
demonstrated that miR-124a is significantly down-regulated after nerve injury. At the same time, 
we observed an up-regulation of miR-221, miR-142-5p, and miR-21 expression. These data 
provided further evidence that miRNAs expression could be injury-regulated.  
In situ hybridization analysis localized injury-regulated miRNAs miR-21 and miR-142-5p 
to regenerating DRG axons 
In the previous experiments we have shown that several miRNAs are induced in an 
injury-regulated pattern in peripheral nerve. The potential sources of miRNAs in crushed nerve 
samples could include glial cells, connective tissue, macrophages, and axons. In the next 
experiment we asked whether the identified differentially expressed miRNAs might be present in 
regenerating DRG neurons. To answer this question, we performed fluorescent in situ 
hybridization (FISH) on murine dissociated DRG neurons plated at a low density to visualize the 
presence of miRNAs in cell bodies and axons. For this experiment, we selected miR-21 and 
miR-142-5p, which showed an upregulation by injury in the miRNA arrays. After FISH, DRG 
preparations were immunostained with TUJ1 antibody against neuron-specific β-tubulin. The 
localization of P-bodies was visualized by immunostaining against GWB IC-6. Analyses of these 
immunofluorescent images revealed presentation of miR-21 and miR-142-5p in DRG cells and 
axons (Fig. 3.6). Interestingly, the distribution of miRNAs in the axon was overlapping with P-
bodies immunostaining included in axon VR. These results demonstrate an interesting possibility 




Table 3.1. Regulation of miRNAs at 4 days after nerve crush. 
Total RNA for the microarray expression analysis was isolated from sciatic nerves, pooled from 
10 mice, at 4d and 7d after the sciatic nerve crush. Both custom and Agilent arrays were done in 
duplicates and repeated two times. Normalization and analyses were performed with GeneSpring 
software (Agilent). Data from custom and Agilent arrays were log2-transformed and median-
center by array. The GeneSpring analysis software was used for the identification of statistically 
significant upregulated or downregulated miRNAs at selected time points. The analysis also 
allowed for identification of a different temporal pattern of expression in the crushed groups 
compared with the control groups at the chosen time. For further analyses we selected three 
miRNAs that were significantly upregulated and on that was significantly downregulated in both 
custom arrays as well as in Agilent arrays. 
Note the similarities in the expressions of miRNAs between 4 d (Table 3.1) and 7 d (Table 3.2) 
















Figure 3.1. Immunoblot analyses for FMRP, Ago2, and p-100 protein in sciatic nerve.  
Proteins were extracted from 3 groups of pooled samples (intact sciatic nerves, the contralateral 
naive nerve and the injured sciatic nerve) at 4 days or 7 days after a conditioning nerve lesion. 
Immunoblot analyses were conducted with primary antibodies against FMRP, AGO2, and p-100.  
Using the expression level in intact nerve as a control, relative densitometry were normalized to 
alpha-tubulin. Quantified bands densitometry showed a more abundant expression of RISC 
component (FMRP, Ago2, p-100) in injured sciatic nerve at both 4 days (A) and 7 days (B) after 
injury (N=3, * indicate P<0.05, ** indicate P<0.01).  Representative immunoblot of FMRP, 







Figure 3.2. Western Blot analyses of P-body components in the sciatic nerve after injury. 
Western Blot analysis of P-body components in the sciatic nerve utilized the primary antibody 
against DCP-1, DCP-2, Rap55, Ro52, and GWB IC6. Pooled samples (6 nerves each sample) 
were extracted from intact sciatic nerves, the contralateral naive nerve and the injured sciatic 
nerve at 4 days or 7 days after a conditioning nerve lesion. Protein levels were quantified by 
band densitometry and normalized to alpha-tubulin at 4 days (A) and 7 days (B) after conditional 
lesion. Immunostaining for DCP-1, the catalytic factor for DCP-2, showed an increase in 
expression in response to injury, whereas the expression of DCP-2, the decapping enzyme in P-
body, decreased after injury at both time points. Immunostaining for GWB IC-6 showed much 
higher GWB IC-6 expression at 4 days and 7 days after injury, while Rap-55 showed no change 
in expression in response to injury. Ro52 expression level was significantly decreased following 
injury.  (N=3, * indicates P<0.05, ** indicates P<0.01) Representative immunoblot of protein 







Figure 3.3. Colocalization of P-body proteins in regenerating DRG axons.  
Dissociated cultures of mouse DRG neurons collected 5 days after a conditioning lesion were co-
labeled with FITC (green) conjugated antibodies to DCP1 (B) and Alexia 594 (red) conjugated 
antibodies to GWB IC-6 (C). TUJ1 (Blue) staining indicated the location of the axon (A). The 
merged images revealed co-localizations of investigated proteins in regenerating axons (D). The 
Z-scanning further confirmed their co-localization on the same level in the axon (E).  White 









Figure 3.4. Number of varicosities along the axon containing P-bodies markedly increases 
after conditioning lesion. 
Low density dissociated DRG cultures were labeled with antibodies to neuronal maker TUJ1 
(Blue), DCP-1 (Green) and GWB IC-6 (Red). Merges of the images revealed the localization of 
the P-bodies in soma and axon. The appearance of P-bodies was limited to varicosities along the 
axon. The fluorescent images in upper panel showed neurons cultures after sciatic nerve crush 
pre-conditioning (A). The images in lower panel showed neurons from naïve side (B). After 
injury, the average number of VR containing P-bodies (white arrows) per neuron has 
















Figure 3.5. Real-time qPCR for miRNAs.  
Graphs indicated relative change in miRNA level. Total RNA was isolated from intact and 
crushed sciatic nerves (n=6). Based on miRNA array data, several miRNAs were selected for 
qPCR verification. Relative quantitation of miRNA level was calculated against the reference 
gene (S12), and a relative fold change was determined using the 2 
–ΔΔCT 
method (n=3, *p<0.05).  








Figure 3.6. Colocalization of miRNAs and GWB in neurons and axons. 
Fluorescent in-situ hybridization for miR-21 (A), miR-142-5p (B) revealed the distribution of 
miRNAs in axon.  Immunofluorescence for neuronal β-tubulin served as a neuronal marker and 
immunostaining for GWB protein exhibited the localization of P-bodies. U6, a small nuclear 
RNA locates only in nucleus was used as one control (C). Scrambled probes were used as 
another negative control. Green fluorescence shows the distribution of miRNAs and U6.  Red 
fluorescence indicates immunodetection of neuronal β-tubulin protein with TUJ1 antibodies 
(1:100).  Blue signals indicate GWB protein.  White arrows indicate fluorescent signals within 
the axons where miRNA and P-bodies components resided. Arrows with tail indicate neuronal 
cell bodies, small arrows show P-bodies, arrow heads indicates the non-neuronal cells (Scale bar 

















Our study demonstrated that the expression of miRNA biosynthetic protein complexes 
was increased following sciatic nerve injury, as well as some miRNAs. Recent studies have 
shown that RNAi machinery exists and is functional in peripheral nerve axons (Buckingham et 
al., 2004, Hengst et al., 2006, Murashov et al., 2007). In addition, stable expression of a number 
of miRNAs that were enriched in the superior cervical ganglia (SCG) axons has recently been 
identified (Natera-Naranjo et al., 2010).  In our previous studies, we demonstrated that miRNA 
biosynthetic enzymes are present in peripheral nerve axons in vivo and in vitro (Murashov et al., 
2007). However, whether the miRNA biosynthetic pathway is involved in peripheral nerve 
regeneration has not been documented yet.  In this report, we investigated the response of 
miRNAs biosynthetic pathway to peripheral nerve injury. Specifically, we found differential 
miRNA levels regulated by injury. In addition, we demonstrated that several components of 
RISC and P-bodies were differentially expressed in the sciatic nerve and DRG axons in response 
to crush injury, supporting a potential physiological role of miRNA pathway in regulation of 
peripheral nerve regeneration.  
Components of RISC and P-bodies respond to injury of peripheral nerve 
In our previous experiments, we detected expression of several RISC components in 
mouse sciatic nerve (Murashov et al., 2007). In the current report, we observed increased protein 
levels of Ago2, FMRP, and p100 in response to sciatic nerve crush. The observed injury-
regulated expression of these RISC components may indicate that induction of RISC may be a 
part of the PNs regenerative response. Interestingly, Ago2 , the pivotal RISC protein, was 
recently detected in P-bodies, as well as in the stress granules (SGs), which suggested a potential 
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functional relationship between RISC, SGs, and P-bodies in physiological response to cellular 
stresses (Leung et al., 2006, Didiot et al., 2009). P-bodies are an important component of the 
miRNA machinery as the sites for either degrading or protecting and sequestering mRNA 
(Parker and Sheth, 2007, Balagopal and Parker, 2009). P-bodies are dynamic complexes whose 
assembly are dependent on, and proportional to, the cytoplasmic pool of translationally repressed 
messenger ribonucleoproteins (mRNPs)  (Teixeira et al., 2005, Franks and Lykke-Andersen, 
2008). Although the complete composition of P-bodies is not yet established, they are known to 
include the decapping enzymes DCP1/DCP2, the activator of decapping Dhh1/RCK/p54, Pat1, 
Scd6/RAP55, Edc3, the Lsm1-7 complex and the exonuclease, Xrn1 (Parker and Sheth, 2007, 
Balagopal and Parker, 2009). In agreement with previous reports that various cellular stresses 
initiate the formation of P-bodies (Balagopal and Parker, 2009), we detected the change in the 
expression level of P-bodies components after crush injury using immunoblotting analyses. 
In particular, we made an interesting observation that sciatic nerve injury led to elevated 
levels of GWB IC-6 and Dcp1, but decreased the expression of Dcp2. The apparent discrepancy 
may be partially explained by recent report in which, in vitro depletion of the decapping enzyme 
Dcp2 caused increased P-bodies assembly (Franks and Lykke-Andersen, 2008). Although Dcp1 
and Dcp2 are both core components of P-bodies, which catalyze removal of the 5’ cap structure 
from mRNA, they are structurally and functionally different. DCP1 behaves as a decapping 
enzyme regulatory subunit, whereas DCP2 functions as a catalytic subunit of decapping enzyme 
(Sheth and Parker, 2003, She et al., 2008). Therefore, decreased level of Dcp2 may result in 
accumulation of undigested mRNAs and thus in additional P-bodies assembly. At the same time, 
another recent observation points out that mammalian cells possess multiple mRNA decapping 
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enzymes and Dcp2 protein may only modestly contribute to bulk mRNA decay in mouse and 
human tissues (Song et al., 2010). 
We also observed an increase in the number and the size of P-bodies after conditional 
nerve lesion in the regenerating DRG axons. It is well known that conditioning sciatic nerve 
crush produces robust regenerative response with concomitant increase in mRNA and protein 
synthesis (Willis and Twiss, 2006). We presume that the increase in the pool of mRNA may 
initiate P-bodies assembly. Indeed, overexpression of a nontranslating mRNA in yeast was 
shown to potentiate P-bodies formation (Teixeira et al., 2005). Moreover, the size and number of 
P-bodies are proportional to the pool of untranslated mRNAs (Teixeira et al., 2005, Parker and 
Sheth, 2007). Therefore, when mRNAs are trapped in association with ribosomes, P-bodies 
decline; conversely, when mRNAs dissociate from ribosomes because of inhibition of translation 
initiation, P-bodies increase in size and numbers (Teixeira et al., 2005, Parker and Sheth, 2007, 
Balagopal and Parker, 2009).  Consequently, nerve crush nerve crush may lead to a larger pool 
of untranslated mRNA and to increase in the number and size of functional P-bodies (Kedersha 
et al., 2005, Koritzinsky et al., 2006). 
We made another intriguing observation that P-bodies were preferentially localized to the 
axon VR. The number of VR was markedly higher in the regenerating versus naïve DRG axons. 
Although the physiological role of varicosities (VR) is not clear their alleged function has been 
associated with presynaptic terminals, places of action potential waveform modulation, and 
organelle accumulation and sequestration (Bennett and Muschol, 2009). In addition, VR were 
described as the sites of mRNA concentration and protein synthesis (Lee and Hollenbeck, 2003). 
Interestingly, it was recently suggested that VR are the sites of clustering of excess growth 
resources along developing neuritis (Malkinson and Spira, 2010). Our data are complimentary to 
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these observations suggesting that P-body machinery localized to VR cab regulate the growth 
resources by managing mRNA pool.  
Identification of miRNAs specifically expressed in injured sciatic nerve  
We used microarrays and RT-PCR to profile miRNA expression changes in the sciatic 
nerve of mice after injury. The results revealed a group of miRNA expressed in an injury-
regulated pattern. For analysis, we chose three most highly upregulated miRNAs, that is miR-21, 
miR-142-5p, and miR-221, as well as brain specific miR-124a, which was significantly 
downregulated after nerve crush. 
Interestingly, miRNAs miR-21 and miR 142-5P were reported to be also up-regulated 
after brain injury (Lei et al., 2009). In addition, miR-221 was found to be relatively abundant in 
distal axons of SCG and had elevated expression level after spinal cord injury (Liu et al., 2009, 
Natera-Naranjo et al., 2010).  It has been reported that the brain-enriched miRNA miR-124 is an 
important regulator of the temporal progression of adult neurogenesis in mice. Knockdown of 
endogenous miR-124 maintained subventricular zone stem cells as dividing precursors, whereas 
ectopic expression led to increased neuron formation. Furthermore, blocking miR-124 function 
during regeneration led to hyperplasias, followed by a delayed burst of neurogenesis (Cheng et 
al., 2009). Although the changes in the miRNA expression profile following injury and 
development have been reported, the mechanism that regulates miRNA expression has not been 
yet elucidated.  In the current article, we revealed that expression of several miRNA biosynthetic 
enzymes were injury-regulated. This let us to propose that the change in levels of miRNA 
biosynthetic proteins may play a role in the injury-regulated expression of miRNAs. 
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Taken together, our data identify a role for the miRNA biosynthetic pathway in 
peripheral nerve response to injury. Further studies should provide important insight into the role 
of specific miRNAs in peripheral nerve regeneration. This finding may have significant clinical 
potential in the treatment of neurodegenerative diseases, specifically those involving peripheral 
nerves. 
Although no previous study has directly associated P-bodies wit peripheral nerve health, 
identification of patients with autoimmunity to GWBs suggests such a role. Clinical studies 
indicate that these patients most often suffer from motor and sensory peripheral neuropathy 
(Bhanji et al., 2007). Although it is not known whether the resulting neuropathy is axonal or glial 
in its origin, it is logical to presume that autoimmune decrease of P-bodies in axon may 
negatively affect intra-axonal translation and become detrimental to axon physiology. 
Conclusion 
This work offers insights into the functional interplay between miRNAs and their 
biosynthetic enzymes in peripheral nerve injury. In conclusion, we show that injury to peripheral 
axons induces changes in the content and distribution of some biosynthetic proteins of the 
miRNA machinery in cultured DRG neurons and their axons. Together with previous findings, 
these observations suggest that, in addition to RISC, other factors such as P-bodies might 
underlie the changes in regenerating axons induced by injury. Those factors probably act in a 
synergistic way thus leading to the promoting regenerative axon growth. 
  
CHAPTER IV: Dicer-microRNA Pathway is Critical for Peripheral 
Nerve Regeneration and Functional Recovery in vivo and 
Regenerative Axon Growth in vitro 
Summary 
Both central and peripheral axons contain pivotal microRNA (miRNA) proteins. While 
recent observation demonstrated that miRNA biosynthetic machinery responds to peripheral 
nerve lesion in an injury-regulated pattern, the physiological significance of this phenomenon 
remains to be elucidated. In the current paper we hypothesized that deletion of Dicer would 
disrupt production of Dicer-dependent miRNAs and would negatively impact regenerative axon 
growth. Taking advantage of tamoxifen-inducible CAG-CreERt:Dicer
fl/fl
 knockout (Dicer KO), 
we investigated the results of Dicer deletion on sciatic nerve regeneration in vivo and 
regenerative axon growth in vitro. Here we show that the sciatic functional index, an indicator of 
functional recovery, was significantly lower in Dicer KO mice in comparison to wild-type 
animals. Restoration of mechanical sensitivity recorded in the von Frey test was also markedly 
impaired in Dicer mutants. Further, Dicer deletion impeded the recovery of nerve conduction 
velocity and amplitude of evoked compound action potentials in vitro. Histologically, both total 
number of regenerating nerve fibers and mean axonal area were notably smaller in the Dicer KO 
mice. In addition, Dicer-deficient neurons failed to regenerate axons in dissociated dorsal root 
ganglia (DRG) cultures.  Taken together, our results demonstrate that knockout of Dicer clearly 
impedes regenerative axon growth as well as anatomical, physiological and functional recovery. 
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Our data suggest that the intact Dicer-dependent miRNA pathway is critical for the successful 





MicroRNAs (miRNAs) are important molecular switches which play a major role in post-
transcriptional gene regulation (Jackson et al., 2010). Pri-miRNAs are initially processed by 
biosynthetic enzymes, Drosha and DGCR8/Pasha, while in cytoplasm RNAse III enzyme Dicer 
cleaves pre-miRNAs into the mature miRNAs (Bernstein et al., 2001, Lee et al., 2003). Dicer 
plays a critical part in the miRNA biosynthetic pathway and the system wide ablation of Dicer in 
mice results in early embryonic lethality (Bernstein et al., 2003). Therefore, to investigate the 
role of miRNAs in the nervous system many groups have used Cre-mediated recombination 
systems to ablate Dicer in a tissue or developmentally specific manner (Cuellar et al., 2008). 
Studies show that during early development, the deletion of Dicer in the neural crest (NC) 
lineage leads to the cell loss in enteric, sensory, and sympathetic nervous systems (Zehir et al., 
2010). During the late embryonic stage cortical-specific Dicer conditional knockout affects 
survival and differentiation of cortical neural progenitors resulting in the abnormal migration of 
neurons in the cortex as examined at E 18.5 (Kawase-Koga et al., 2009). Postnatally, conditional 
loss of Dicer in excitatory forebrain neurons disrupts cellular morphogenesis, resulting in an 
array of phenotypes including microcephaly, reduced dendritic branch elaboration, and increased 
cortical apoptosis (Davis et al., 2008). Loss of Dicer in dopaminoceptive neurons is associated 
with ataxia, reduced brain size, and decreased lifespan to 10-12 weeks (Cuellar et al., 2008).  
Similarly, conditional inactivation of Dicer in Purkinje cells leads to relatively rapid 
disappearance of Purkinje cell-expressed miRNAs, followed by a slow cerebellar degeneration 
and development of ataxia between 13 to 17 week of age (Schaefer et al., 2007).  
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Thus while these data strongly suggest an indispensable role of miRNAs during neural 
development and maturation in the CNS, little information is available on the role of miRNAs in 
the adult PNS. Although no reports have directly linked miRNA regulation with peripheral nerve 
physiology, recent observations show that loss of Dicer in Schwann cells may arrest Schwann 
cell differentiation (Bremer et al., 2010), alter myelin-related gene expression (Pereira et al., 
2010), and cause a severe neurological phenotype resembling congenital hypomyelination (Yun 
et al., 2010). Interestingly, components of RNA-induced silencing complex (RISC) and mRNA-
processing bodies (P-bodies), which are the local foci of mRNA degradation, have been detected 
in severed sciatic nerve fibers and regenerating dorsal root ganglia (DRG) axons in vitro (Hengst 
et al., 2006, Murashov et al., 2007, Wu et al., 2011a). In addition, a comprehensive list of 
miRNAs residing within the distal axonal domain of superior cervical ganglia has recently been 
reported (Natera-Naranjo et al., 2010). Thus, current observations suggest that miRNAs may 
play an important regulatory role in peripheral nerve health even after development. 
In the current study we asked whether the genetic ablation of Dicer would affect 
peripheral nerve regeneration. Taking advantage of tamoxifen-inducible CAG-CreERt:Dicer
fl/fl
 
knockout mice (Dicer KO), we investigated the results of Dicer deletion on sciatic nerve 
regeneration in vivo and regenerative axon growth in vitro. Here we show that deletion of Dicer 
impaired nerve regeneration according to functional behavioral tests, electrophysiological and 
histological analyses.  In addition, Dicer-deficient neurons failed to regenerate axons in 
dissociated dorsal root ganglia (DRG) cultures.  To the best of our knowledge, this is the first 
demonstration that the intact Dicer-dependent miRNA pathway is necessary for the successful 





Tamoxifen treatment induced Dicer gene knockout in sciatic nerve. 
To confirm that tamoxifen treatment could activate Cre expression and result in Dicer 
KO, we used a ROSA26 Cre reporter gene. All animals carried ROSA26 stop/flox locus annexed 
to a lazZ reporter, in which lazZ expression was conditional upon the removal of the floxed stop 
codon. When Cre recombinase was expressed, it excised the genomic region between the two 
loxP sites, allowing expression of lazZ. The breeding pairs of CAG-CreERt:Dicer
fl/fl  
were 





. X-gal staining for sciatic nerves from those offspring showed that 
only the CAG-CreERt:Dicer
fl/fl
 mice treated with tamoxifen exhibited blue tissue staining. For 
the other two control groups of mice neither the CAG-CreERt:Dicer
fl/fl
 mice with vehicle 
treatment nor the Dicer
fl/fl
 littermates with tamoxifen administration showed any staining in their 
tissues (Fig. 4.1A). These results confirmed that tamoxifen treatment successfully activated Cre 
recombinase in CAG-CreERt:Dicer
fl/fl
 mice.  CAG-CreERt:Dicer
fl/fl
 mice receiving vehicle 
injection and Dicer
fl/fl
 mice receiving tamoxifen treatment lacked Cre expression, and therefore, 
had no lacZ expression. 
The ablation of Dicer expression after tamoxifen treatment in CAG-CreERt:Dicer
fl/fl
 mice 
was assessed by Western blot analysis. Sciatic nerves were collected both at the day of nerve 
crush and 21 days after nerve injury. Western blot data provided the evidence that at both time 
points, there was a significant decrease in the Dicer expression at the protein level in Dicer KO 
group (Fig. 4.1B). On the day of nerve crush, Dicer expression in the sciatic nerve was down-
regulated to 42 ± 2.09% of the vehicle treated group level. At 21 days after nerve crush, Dicer 
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expression in the knockout group was decreased to 32 ± 2.33% of the vehicle treated group level, 
possibly reflecting over time depletion of Dicer protein pool (Fig. 4.1C).   
To confirm these data at the mRNA level, tissue samples were collected from 3 groups of 
mice at 2 different time points, and total RNA was isolated from sciatic nerves. Quantification of 
3 independent RT-qPCR experiments revealed that, tamoxifen treatment reduced Dicer mRNA 
levels to 40 ± 6.11% and 27 ± 5.31% in sciatic nerve at day 0 and day 21 respectively (Fig. 
4.1D), when compared to two controls. Since Dicer is a key enzyme in the microRNA biogenesis 
pathway, we used RT-qPCR to determine the effect of Dicer deletion on microRNA expression. 
The expression levels of the following 4 different miRNAs, miR-199a, miR-21, miR-142-5p and 
miR9, were significantly down regulated (Fig. 4.1E, F) following inducible Dicer deletion. At 
day 0, the expression levels of miR-199a, miR-21, miR-142-5p and miR-9 were reduced to 64 ± 
3.51 %, 42.67 ± 7.27%, 35.33 ± 3.18%, and 38.33 ± 9.39% respectively in comparison with the 
control groups, and at day 21, the expression levels of miR-199a, miR-21, miR-142-5p and miR-
9 were reduced to 56.67 ± 9.77, 38 ± 9.07%, 28.67 ± 4.10%, and 26 ± 3.78%, respectively.  
These results confirmed that Cre activation induced by tamoxifen treatment in CAG-
CreERt:Dicer
fl/fl
 mice led to the ablation of Dicer and marked loss of miRNAs expression in the 
nervous system. 
Dicer deletion delayed functional recovery in walking corridor test 
In order to determine the effect of miRNA depletion on the recovery of motor function, 
we performed a walking corridor behavioral test (N = 20 for each group). As shown in Fig 4.2A, 
during the baseline test, the SFI was normal (close to zero) for 3 groups of mice before sciatic 
nerve crush. Two days after nerve crush, the values of SFI were close to -100 (vehicle control 
91 
 
group: -91.51 ± 2.83; no-Cre control group: -102.4 ± 2.70; Dicer KO group: -96.80 ± 2.69) in all 
three groups of the mice. The SFI was recovering during the observation period of three weeks. 
At earlier time points, there were no significant differences between the Dicer KO group and two 
control groups (Day 4: vehicle control group: -84.45 ± 3.29; no-Cre control group: -78.27 ± 
7.54; Dicer KO group: -88.75 ± 2.43. Day7: vehicle control group: -82.23 ± 2.43; no-Cre control 
group: -70.27 ± 2.70; Dicer KO group: -84.54 ± 2.20). However, although the trends for the 
development of SFI were similar for the 3 groups of mice, the SFI values of Dicer KO were 
slightly lagging behind. The SFI values for Dicer KO group at day 14 and day 21 after injury 
became significantly lower (P<0.05) than those of two control groups (Day 14: vehicle control 
group: -34.71 ± 3.78; no-Cre control group: -25.49 ± 6.93; Dicer KO group: -61.00 ± 5.38. 
Day21: vehicle control group: 24.56 ± 2.22; no-Cre control group: -14.07 ± 4.71; Dicer KO 
group: -43.53 ± 7.49.). It should be noted that, at day 21, the SFI value of the no-Cre control 
group resembled the pre-operation level, whereas the SFI value of the Dicer KO group was still 
significantly lower than pre-operation level. Thus, the data demonstrated that loss of Dicer 
resulted in a slower recovery of motor function.   
Dicer deletion resulted in a delayed recovery from allodynia. 
In our experiments, we used the von Frey test to assess pre-injury mechanical sensitivity 
and the injury-induced changes in mechanical sensitivity following Dicer deletion (N = 15 for 
each group). Two pre-injury tests were used to determine the baseline value and the tests to 
evaluate the recovery of the sensory function were conducted 2, 4, 7, 14, and 21 days after 
injury. Following sciatic nerve injury, mice typically became hypersensitive and responded to 
filaments of lesser intensities, indicating the presence of mechanical allodynia (Vogelaar et al., 
2004). In our experiments, the decrease in the threshold was observed at the first post-injury 
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behavioral test and progressed with time (Fig. 4.2B). During the second week after injury, mice 
in the two control groups showed signs of recovery from allodynia. From day 7 to day 14, the 
sensory threshold of the control animals increased from 32.09 ± 4.5% to 41.56 ± 4.73% of pre-
operation levels, whereas the Dicer KO further decreased their thresholds to mechanical stimuli, 
from 38.01 ± 6.4% to 33.33 ± 6.07% of pre-operation level. On the last day of the observation 
periods (Day 21), there were significant differences in the sensory thresholds between control 
groups and Dicer KO group (vehicle control group: 50.34 ± 6.92; no-Cre control group: -51.03 ± 
5.71; Dicer KO group: -26.57 ± 3.36, P<0.05, N = 15). Thus, the significantly lower mechanical 
withdrawal thresholds in Dicer KO at Day 21 indicated the delayed recovery from allodynia. 
Electrophysiological evaluation of sciatic nerve regeneration 
The electrophysiological assessments, performed at 14 days and 21 days after nerve 
crush, provided further evidence for the delayed physiological recovery of crushed sciatic nerve 
in Dicer KO animals.  Nerve conduction velocity (NCV) decreased after crush and then was 
restored upon the regeneration of nerve fibers (Fig. 4.3 and 4.4). At both 14 (Fig. 4.3B) and 21 
(Fig. 3.4B) days after injury, NCV was significantly slower in Dicer KO group compared with 
controls (Day 14: vehicle control group: 5.10 ± 0.43 m/s; no-Cre control group: 5.96 ± 0.89 m/s; 
Dicer KO group: 2.28 ± 0.38 m/s (Fig. 4.3 B2). Day 21: vehicle control group: 15.14 ± 0.74 m/s; 
no-Cre control group: 13.1 ± 1.23 m/s; Dicer KO group: 6.40 ± 0.83 m/s. N = 5, P<0.05 (Fig. 
4.4B)). The increase of NCV from day 14 to day 21 was also significantly smaller in Dicer KO 
group (vehicle control group: 100 ± 7.33%; no-Cre control group: 71.22 ± 12.27%; Dicer KO 
group: 46.94 ± 9.07% (Fig. 4.4C)). After nerve injury, the waveforms of the evoked action 
potentials recorded from distal sciatic nerve had dramatically changed. Instead of single 
identifiable CAPs, several waveform signals with lower amplitude were recorded (Fig. 4.3A1, 
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4.3A2). A quantification of these data, after rectification and integration of the appropriate time 
windows, revealed that during the period of recovery, both at 14 days (Fig. 4.3C2) and 21 days 
(Fig. 4.4D), the response was considerably smaller in the Dicer KO group. At 14 days after nerve 
crush (Fig. 4.3C2), the CAP in vehicle treated groups was 100 ± 20.24%; in no-Cre animals was 
124.5 ± 26.73%, while the action potential in Dicer knock out animals was 49.96 ± 15.21%.  At 
21 days (Fig.4.4D), similar to day 14 data, Dicer KO (32.13±8.14%) displayed delayed recovery 
comparing to vehicle treated (100 ± 21.89%) or no-Cre group (100.8 ± 18.76%) at 21 days. The 
wave shapes recorded from control groups 21 days after nerve crush also showed greater 
restoration compared with the group of Dicer KO. 21 days after nerve injury, the initial response 
amplitude remained reduced and was followed by several small waves (Fig 4.4A upper graph). 
In the Dicer KO group, the response remained delayed and only small waveform signals were 
recorded from the distal end of the nerve, which exhibited wave shapes similar to 14 day’s data 
(Fig. 4.4A lower graph).  
The effect of Dicer KO on anatomical recovery of crushed sciatic nerve 
Semi-thin cross sections of sciatic nerves were stained with osmium tetroxide and 
Richard’s dye to help visualize myelinated nerve fibers. Myelinated nerve fiber mean areas as 
well as the number of myelinated nerve fibers were quantified with NIH ImageJ software. At day 
14 after nerve crush, the sizes and number of the individual myelinated nerve fibers of 
regenerating nerves in Dicer KO group were smaller than those observed in control nerves (Fig. 
4.5A-C). The compromised regeneration in Dicer mutants became apparent at 21 days (Fig. 
4.5D-F) when the difference in size and numbers of axon fibers between the control and the 
knockout groups reached statistical significance (Fig. 4.5G and H) (number of regenerated nerve 
fibers: vehicle control group: 1349.50 ± 28.04; no-Cre control group: 1345.50 ± 36.37; Dicer 
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KO group: 1115.50 ± 52.73; myelinated axon area: vehicle control group: 4.13 ± 0.05; no-Cre 
control group: 4.05 ± 0.09; Dicer KO group: 3.26 ± 0.09. N = 6, P<0.05). Thus, the histological 
data confirmed that Dicer deletion impairs anatomical recovery of peripheral nerve following 
crush injury. 
Direct effect of Dicer deletion on regenerating DRG neurons in vitro 
To assess the direct effects of Dicer deletion on regenerative axon growth, in vitro studies 
were performed in dissociated DRG neuronal cultures. DRGs from tamoxifen or vehicle 
treatment CAG-CreERt:Dicer
fl/fl
 mice and tamoxifen treated Dicer
fl/fl
 mice were collected at day 
5 after conditioning sciatic nerve lesion. After such injury the regenerative capacity of the 
neurons are improved and can be detected as an increased axonal outgrowth in comparison to 
uninjured contralateral neurons. The neuronal cells were dissociated and plated sparsely on 
coverslips coated with poly-d-lysine and laminin. Immunostaining with the neuronal marker TUJ 
was used to visualize the neuronal cell bodies and axons in the cultures. The measurement of 
axon length and the counting of branches demonstrated that, in the absence of Dicer, the 
regenerative axon growth was significantly impaired compared to control groups (Fig. 4.6).  
Mean axon length of Dicer KO DRG neuron was approximately 200 µm after 24 hr 
culturing. In the two control groups, dissociated DRG neurons had more robust regenerative 
growth. The mean axon length was around 350 μm after 24 hr culturing.  For statistical analysis, 
we normalized all of the data to the vehicle treated group. DRG neurons from the tamoxifen 
treated Dicer
fl/fl
 mice had approximately the same axon length in comparison with vehicle 
treatment CAG-CreERt:Dicer
fl/fl
 group (vehicle control group: 100 ± 6.75%, no-Cre control 





group decreased to 39.83 ± 4.82% of the control level, due to Dicer KO. Dicer 
deletion also significantly inhibited axon branching. After 24hr of culturing, the number of 
branches in Dicer KO DRG neurons was 63% lower than that of the two control groups (Vehicle 
control group: 100 ± 6.6%; no-Cre control group: 105.10 ± 9.75%; Dicer KO group: 36.81 ± 
5.26%. N = 30, P<0.05 (Fig. 4.6E)). Therefore, in vitro studies provided further evidence that the 
intact Dicer-dependent miRNA pathway is critical for regenerative axon growth in isolated 
neurons. 
The same assessments were also performed on DRG neurons with inducible Dicer KO in 
neuronal cell cultures. To exclude the influence from the loss of Dicer in other types of cells, 
mice did not receive any treatments until euthanasia. All treatments were applied to neuronal cell 
cultures in vitro. As with the previous studies, we had 3 groups of cell culture in this study. 
DRGs form Dicer
fl/fl
 mice cultured with DMSO was the vehicle treated group. DRGs collected 
form Dicer
fl/fl
 mice with tamoxifen in culture media was considered the no-Cre control group. 
DRGs from CAG-CreERt:Dicer
fl/fl 
mice with tamoxifen in the culture media was the Dicer 
knockout group. The differences in the regenerative growth between Dicer knockout group and 
control groups resulted from the loss of Dicer expression in neuronal cells. 
From the quantified data shown in Figure 6 F and 6 G, DRG neurons with Dicer 
knockout in vitro exhibited similarly impaired regenerative axon growth as with Dicer knockout 
in whole animals. The axon length in Dicer KO group decreased to 61.79 ± 5.79% of the vehicle 
control group level, whereas the tamoxifen treated DRG neurons from Dicer
fl/fl
 mice (the no-Cre 
group) had longer axon (not statistic significant), in comparison with vehicle treated group 
(vehicle control group: 100 ± 11.17%, no-Cre control group: 121.1 ± 5.28% (Fig. 4.6F)). 
Similarly, Dicer deletion in vitro also significantly inhibited axon branching. The number of 
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branches in Dicer knockout group was 66.75% of the control groups (Vehicle control group: 100 
± 12.35%; no-Cre control group: 95.68 ± 8.35%; Dicer KO group: 66.73 ± 6.46%.  N = 30, 
P<0.05 (Fig. 4.6G)). Our results showed that loss of Dicer ally specific in neuronal cells 
inhibited neurite outgrowth, and the phenotype was more severe when Dicer knockout was 
induced at whole animal level. These data suggested that the delayed nerve regeneration can be 
explained by the loss of Dicer in neuronal cell, and loss of Dicer in other cell types in peripheral 




Figure 4.1. Cre activation induces loss of Dicer in CAG-CreERt:Dicer
fl/fl
 mice.  
Tamoxifen treatment of CAG-CreERt:Dicer
fl/fl
 mice activated Cre recombinase, under the 
control of the estrogen promoter. (A) Cre activation was assessed by X-gal staining of sciatic 
nerves. LacZ expression was not observed in two control groups: vehicle treated CAG-
CreERt:Dicer
fl/fl
 mice (left) and tamoxifen treated Dicer
fl/fl
 mice (middle). X-gal staining was 
obvious in sciatic nerve of tamoxifen treated CAG-CreERt:Dicer
fl/fl
 mice (right). (B) Western 
blot shows successful depletion of Dicer in sciatic nerve. Sciatic nerves were collected from 3 
groups of mice (Tamoxifen treated CAG-CreERt:Dicer
fl/fl
 mice, vehicle treated CAG-
CreERt:Dicer
fl/fl
 mice, and tamoxifen treated Dicer
fl/fl
 mice) at both the day of sciatic nerve crush 
surgery and 21days after nerve crush. (C) Protein levels of Dicer were quantified by band 
densitometry and normalized to α-tubulin level. (D) Decrease in Dicer expression at mRNA 
level in pooled samples of sciatic nerves after tamoxifen treatment measured by Real-Time 
qPCR. (E), (F), Real-Time qPCR confirmed declined levels of selected miRNAs after Cre 








Figure 4.2. Behavioral tests reflect impaired restoration of sensory and motor function in 
Dicer KO.   
(A) Sciatic functional index (SFI) ± the standard error of the mean (SEM) shows the recovery of 
motor function from sciatic nerve crush with/without Dicer deletion over the course of time. 
Tamoxifen treated CAG-CreERt:Dicer
fl/fl
 mice (Dicer KO) demonstrated delayed recovery 
compared to vehicle treated animals and tamoxifen treated Dicer
fl/fl
 mice. The difference between 
SFI reached statistical significance at day 14 and day 21 (N=20, * p<0.05). (B) von Frey test 
assessed mechanical sensitivity at 2, 4, 7, 14, and 21 days after nerve injury. All data were 
normalized to pre-injury baseline level. At 21 days post-injury, the threshold to mechanical 
stimuli was significantly lower in the Dicer KO group (N=15, * p<0.05). Tamoxifen treated 
CAG-CreERt:Dicer
fl/fl
 mice are represented by dot lines, tamoxifen treated Dicer
fl/fl
 mice are 
represented by dashed lines, and vehicle treated CAG-CreERt:Dicer
fl/fl









Figure 4.3. Electrophysiological evaluations of sciatic nerve functional recovery at 14 days 
after sciatic nerve crush.  
(A) Typical examples of responses recorded from the distal side of the sciatic nerve after 
electrical stimulation. Stimulation of the proximal side of the sciatic nerves (500 μA, 100 μsec) 
induced a fast response with a single CAP in the intact nerve and a delayed and spread-out 
response in the regenerating nerve. (A1) Compound action potentials (CAPs) recorded from the 
controlateral uninjured sciatic nerve. The signals recorded from vehicle treated mice and 
tamoxifen treated Dicer
fl/fl
 mice (no Dicer deletion) were similar to that recorded from tamoxifen 
treated CAG-CreERt:Dicer
fl/fl
 mice (Dicer KO). The duration from the stimulation artifact to 
onset of compound action potential was used for the calculation of nerve conduction velocity. No 
difference of NCV (B1) or rectified and integrated compound action potential amplitude (C1) was 
observed between the different groups in the controlateral uninjured nerves. (A2) Delayed 
responses were recorded from the injured sciatic nerves 14 days after crush. Note the additional 
delay in the response of Dicer KO sciatic nerve of nearly 6 ms, indicating a reduced nerve 
conduction velocity, and suggesting a slower rate of functional recovery after injury in the Dicer 
KO animals.(B2) Animals from all 3 groups gradually restored NCV on the crushed nerve with 
time. However, animals with Dicer KO (tamoxifen treated CAG-CreERt:Dicer
fl/fl
) have a 
significantly lower NCV compared with control animals (tamoxifen treated Dicer
fl/fl
 mice and 
vehicle treated mice). (C2) Dicer KO animals also exhibited smaller rectified and integrated 











Figure 4.4. Electrophysiological evaluations of sciatic nerve functional recovery at 21 days 
after sciatic nerve crush.  
(A) Typical examples of delayed responses were recorded from the injured sciatic nerve 21 days 
after nerve crush with electrical stimulations at the proximal ends. Note the appearance of a 
quick response in signals from the control animals, while Dicer KO sciatic nerve still showed 
only a delayed response without any fast component. Waveform signals recorded at 14 days after 
nerve injury are repeated from Figure 3 A2 for comparison purposes. (B) The NCV were 
compared between control groups (vehicle treated mice and tamoxifen treated Dicer
fl/fl
) and 
Dicer KO groups (tamoxifen treated CAG-CreERt:Dicer
fl/fl
). Animals with Dicer KO had a 
significantly lower NCV. (C) Difference in NCV between 14 and 21 days in three groups of 
mice. Although animals from all groups showed restored NCV with time, the increase in NCV 
was significantly smaller in Dicer KO animals from day 14 to day 21. (D) Dicer KO animals 









Figure 4.5. Light microphotographs of semi-thin sections of sciatic nerve give evidence of 
delayed regeneration of sciatic nerve fibers after Dicer deletion.  
Transverse semi-thin sections of sciatic nerve distal to the injury sites were examined under light 
microscopy. Light micrographs of nerves from vehicle treated group (A, D) and tamoxifen 
treated Dicer
fl/fl
 group (B, E) were compared with that of tamoxifen treated CAG-
CreERt:Dicer
fl/fl
 (Dicer knockout) group (C, F) at 14 days (upper panel) and 21 days (lower 
panel) post injury. Images obtained at higher magnification (D1, E1, F1) clearly showed the 
regenerating axons with new myelin wrappings. Note smaller axons with thinner myelin in Dicer 
knockout group (F1) compared to the two control groups (D1, E1), The statistical analysis showed 
that the number of myelinated axons (G) and myelinated mean axon area (H) at day 21 after 









Figure 4.6. In vitro study showed an arrested regenerative axon growth after Dicer 
deletion.  
(A) DRG culture from vehicle treated CAG-CreERt:Dicerfl/fl. (B) DRG culture from Dicerfl/fl 
mice with tamoxifen treatment. (C) DRG culture from CAG-CreERt:Dicerfl/fl (knockout) mice 
with tamoxifen treatment. Fixed cells were incubated with antibodies against neuronal marker β-
tubulin and signals were visualized with TX-Red conjugated secondary antibody. The statistical 
analyses were performed on the length (D) and the branch number (E) of the axons in dissociated 
DRG cultures. DRGs cultured from Dicer KO had significantly less axon branches and shorter 
axons compared with control groups. When DRGs were collected with animals with no treatment 
and tamoxifen was applied to cell cultures to induced neuronal cell specific Dicer knockout, 
similar inhibition in neurite growth was observed. Quantified data showed a significant decrease 
of the length (F) and the branch number (G) of the axons in dissociated DRG from CAG-
CreERt:Dicerfl/fl mice with tamoxifen treatment (Dicer Knockout group) comparing to two 









Dicer ablation resulted in delayed functional recovery  
Our experiments demonstrated a delayed functional recovery of Dicer KO in comparison 
to control groups in walking corridor and von Frey behavioral tests. Walking corridor SFI data 
are complementary to a recent study that showed progressive locomotor dysfunction and 
muscular atrophy after specific ablation of Dicer in post-mitotic postnatal motor neurons 
(Haramati et al., 2010). The authors also reported the perturbed expression of neurofilament 
subunits in their Dicer KO model and linked this observation to deregulation of miR-9 (Haramati 
et al., 2010). In another observation, loss of miR-206 accelerated progression of amyotrophic 
lateral sclerosis (ALS) and diminished survival (Williams et al., 2009). It was also suggested that 
the beneficial actions of miR-206 were mediated by muscle-derived factors that promote nerve-
muscle interactions in response to injury of motor neurons (Williams et al., 2009). Therefore, our 
SFI data together with current observations suggest a significant role of miRNAs in motor 
neuron health and response to injury. 
We have also observed delayed recovery of sensory function in Dicer KO using von Frey 
analysis. This observation is supported by previous findings which revealed that Dicer deletion 
led to severe defects in axon pathfinding of retinal ganglion cell (RGC) at the optic chiasm 
(Pinter and Hindges, 2010).  This work has shown that miRNAs are essential regulatory elements 
for correct axon guidance decisions and the establishment of circuitry during neural 
development. Another recent report demonstrated that deletion of Dicer in Nav1.8
+
 sensory 
neurons attenuated or abolished inflammatory
 
pain with corresponding decrease of nociceptor-
specific
 
pre-mRNA transcripts (Zhao et al., 2010). Furthermore, spinal nerve ligation changed 
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expression of the sensory organ-specific cluster of miRNAs in injured rat DRGs, which was 
linked to mechanical hypersensitivity (Aldrich et al., 2009). Thus, recent observations indicated a 
possible role for miRNAs in mechanism of pain.  It has been recently proposed that miRNAs 
may participate in the regulatory mechanisms of genes associated with the pathophysiology of 
chronic pain as well as the nociceptive processing following acute noxious stimulation (Kusuda 
et al., 2011). Collectively, our von Frey data and previous reports propose a critical role of 
miRNAs in sensory neuron physiology and response to injury.  
Dicer deletion impaired electrophysiological recovery.  
CAP amplitude and NCV are routinely used as two indexes to evaluate progression of 
nerve regeneration (Shen et al., 2008, Sun et al., 2009). CAP and NCV may be affected by both 
damage to peripheral nerve and by muscle atrophy caused by denervation of target tissue 
(Navarro et al., 2007).  To avoid muscle influence, this study was performed on isolated sciatic 
nerve preparation. Our electrophysiological data provided further evidence of the impaired nerve 
regeneration in the absence of Dicer. Measured NCV and CAP were significantly lower in Dicer 
KO animals at 14 and 21 day of regeneration.  The delayed recovery of electrophysiological 
indexes may be explained by a failure in axon outgrowth and/or remyelination of the new fibers. 
After peripheral nerve injury, Schwann cells provide trophic and mechanical support for 
regenerating axons and subsequently form new myelin sheath (Navarro et al., 2007). 
Interestingly, Schwann cell-specific deletion of Dicer fully arrest Schwann cell differentiation, 
resulting in early postnatal lethality (Bremer et al., 2010). Specifically, most Schwann cells arrest 
at the promyelinating stage (Pereira et al., 2010). In vivo, this results in a neurological phenotype 
similar to congenital hypomyelination (Yun et al., 2010).  Conversely, several miRNAs were 
identified as regulators of myelination (Bremer et al., 2010, Yun et al., 2010). For instance, miR-
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138 was described as a potential repressor of key immature Schwann cell genes, thus facilitating 
myelination (Yun et al., 2010). Another miRNA, miR-219, was demonstrated to play a critical 
role in enabling the rapid transition from proliferating oligodendrocyte precursor cells to 
myelinating oligodendrocytes (Dugas et al., 2010). Therefore, current data suggest that during 
nerve regeneration, disrupted miRNA biogenesis could result in failed remyelination and 
consequently in loss of saltatory propagation. Ablation of Dicer might also hamper the ionic 
remodeling process. Indeed, recent observation has identified a group of miRNAs regulating 
voltage-gated sodium channel Scn11a, alpha 2/delta1 subunit of voltage-dependent Ca-channel, 
and purinergic receptor P2rx ligand-gated ion channel 4 in the spinal nerve ligation model of 
neuropathic pain (von Schack et al., 2011). Thus, the impaired function in ion channels might be 
another factor potentially contributing to the delayed recovery of peripheral nerve 
electrophysiological characteristics.  
Delayed anatomical recovery in Dicer mutants 
Our histological evaluation showed that Dicer KO reduced the total number of 
myelinated axons as well as diminished the mean axonal area in regenerating sciatic nerve. 
Previous studies demonstrated the critical role for miRNAs in the transition of Schwann cells 
from the pro-myelin stage to the myelinating stage (Bremer et al., 2010, Pereira et al., 2010, Yun 
et al., 2010). Ultrastructural and biochemical analysis of sciatic nerves from postnatal mice 
revealed a severe myelination defect in Schwann cell-specific Dicer KO animals (Bremer et al., 
2010, Pereira et al., 2010, Yun et al., 2010). Dicer-deficient Schwann cells not only failed to 
myelinate, but were also unable to form normal Remak bundles of unmyelinated small-caliber 
axons (Bremer et al., 2010). Western blot analyses of Schwann cell-DRG co-cultures grown 
under myelinating conditions revealed that reduced levels of Dicer led to a decrease in the 
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expressions of myelin basic protein and protein zero, which were accompanied by significant 
reductions in synthesis of myelin (Verrier et al., 2010). Loss of Dicer specifically in Schwann 
cells can also result in signs of axonal degeneration, which suggest the involvement of miRNAs 
in the maintenance of axon integrity (Pereira et al., 2010).  Taken together, our data and previous 
findings suggest that ablation of Dicer might lead to myelination defect, perturbation of axon 
integrity and consequently to the failure of axon to grow back. 
Dicer ablation impaired regenerative ability of PNS neuron in vitro 
To answer the question whether the loss of Dicer could directly impact regenerative 
ability of PNS neuron, we performed a study in dissociated DRG cultures after conditioning 
sciatic nerve lesion. Interestingly, while conditioning lesion resulted in robust axon outgrowth in 
wild type neurons, Dicer-deficient neurons exhibited striking decrease in axon length and 
branching-arborization. The observed regenerative failure in DRG neurons after ablation of 
Dicer provided new evidence that miRNA pathway per se may play a critical role in intrinsic 
mechanism of axon growth.  Several previous studies implicated miRNAs in translational control 
in dendrite outgrowth, as well as synaptic plasticity (Ashraf et al., 2006, Siegel et al., 2009). For 
example, miR-134, which is localized at synaptic sites, inhibits translation of lim-domain-
containing protein kinase1 (Limk1) mRNA. Limk1 regulates actin filament dynamics and its 
ablation resulted in abnormalities in dendritic spine structure (Schratt et al., 2006).  In addition, 
miR-134 constrains neuritogenesis by down-regulating the expression of its target Pumillio, an 
evolutionarily conserved dendritogenesis promoting factor (Fiore et al., 2009). MiR-138 controls 
the expression of acyl protein thioesterase 1 (APT1), an enzyme regulating the palmitoylation 
status of proteins that are known to function at the synapse (Siegel et al., 2009). Recent studies 
have also shown that in cultured cortical and hippocampal neurons, miR-132 functions 
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downstream from CREB to mediate dendritic growth and spine formation. Deletion of the miR-
212/132 locus caused a dramatic decrease in dendrite length, arborization, and spine density 
(Magill et al., 2010). Thus, while previous reports demonstrated an important role of miRNAs in 
neurito- and dendritogenesis our current observation revealed a critical role of Dicer-dependent 
miRNA pathway in axonogenesis.  
Potential role of Dicer-dependent miRNAs in nerve regeneration 
Our data clearly showed that albeit Dicer KO animals did recover after sciatic nerve 
crush, the recovery was significantly slower than in wild type controls. The remaining 
regenerative ability of peripheral nerves in Dicer mutants could be explained by remaining 
miRNAs, which were still detectable in the tamoxifen-treated samples. According to the 
literature, the tamoxifen-inducible Dicer KO usually results in around 80% elimination of Dicer 
mRNA (Pereira et al., 2010, Albinsson et al., 2011). Since in our study activation of Cre did not 
completely eliminated Dicer expression in sciatic nerves either, it is conceivable that the 
remaining gene was still functional. In addition, the mature miRNAs appear to be rather stable 
(O'Rourke et al., 2007) and could continue to function for quite some time before being 
completely degraded (Kawase-Koga et al., 2009).  Therefore some stable miRNAs could also 
contribute to the process of nerve regeneration even after Dicer deletion. Conversely, some 
miRNA species can still be processed by alternative Dicer-independent biogenesis pathway 
recently uncovered in vertebrates (Yang and Lai, 2010). In this pathway, the pre-miRNA is 
loaded into Ago2 and then cleaved by the Ago2 catalytic center to the mature form (Cheloufi et 
al., 2010). Thus, Dicer-independent miRNA biogenesis pathway might be another potential 
source of miRNAs production, and therefore provide some functional compensation after the 




In conclusion, we have provided the first evidence that the intact Dicer-mediated 
miRNAs pathway is required for effective and timely regeneration of peripheral nerve in vivo 
and regenerative axon growth in vitro. Axon loss has been largely neglected as a therapeutic 
target in a variety of neurological symptoms and disorders including multiple sclerosis, stroke, 
traumatic brain and spinal cord injury, peripheral neuropathies and chronic neurodegenerative 
diseases including Alzheimer’s (Coleman and Perry, 2002). Understanding how axon-
degeneration/regeneration process is initiated by these diverse insults could lead to new 
treatments. We anticipate that our study could pave the way for further explorations of miRNA-
regulated regenerative mechanisms in the peripheral as well as central nervous systems and 
possibly herald novel miRNA based therapies of neurological disorders and injuries.  
  
CHAPTER V: Injury-induced miR-431 Promotes Regenerative 
Axon Growth in DRG Neurons 
Summary 
miRNAs are small, non-coding RNAs that function as important post-transcriptional 
regulators in developmental and physiological processes. Our previous work showed that 
peripheral nerve axons in vivo and in vitro contain functional miRNA machinery that would 
respond to peripheral nerve injury. In addition, we demonstrated that the deletion of Dicer, a key 
enzyme responsible for generation of miRNAs, can delay regenerative axon growth in vivo and 
in vitro. These studies have indicated that miRNAs are likely to be important mediators of 
neuronal plasticity during peripheral nerve regeneration. In this study, we reveal a group of 
injury-regulated miRNAs in dorsal root ganglion (DRG) neurons after conditioning sciatic nerve 
lesion by miRNA array analyses. Among those miRNAs, miR-431 was highly induced in DRG 
neurons following sciatic nerve crush. In dissociated murine DRG neurons, the gain and loss of 
function analyses for miR-431 revealed that overexpression of miR-431 promoted neurite 
outgrowth. Potential gene targets for miR-431 were predicted by bioinformatics tools and 
validated experimentally. Wnt pathway-related transmembrane protein Kremen1 was the target 
for miR-431. The reverse correlation between the expression of Kremen1 and miR-431 was 
proven with RT-qPCR at mRNA level and Western blot at protein level. miR-431 induced 
association between Kremen1 mRNA and RISC was shown by cross linked 
immunoprecipitation. These data show that miR-431 could be an important regulator of 
regenerative axon growth and a promising candidate for the future miRNA based therapies that 




After axonal injury, changes occur in the region of the axotomized neuronal cell bodies 
as well as in the microenvironment immediately adjacent to the site of injury (Zigmond, 2011). 
Further, gene expression profiles in neurons, such as DRG (Kuo et al., 2011), superior cervical 
sympathetic ganglia (SCG) (Boeshore et al., 2004), and retinal ganglion cells (RGC) (McCurley 
and Callard, 2010) also are altered after axotomy. At the protein level, increases and decreases of 
gene expressions have also been documented, which translate into phenotypic changes that 
enable the regeneration of severed axons (Strickland et al., 2011). 
Considerable attention has focused on the underlying mechanisms that contribute to 
neural regeneration. The studies on DRG neurons following sciatic nerve injury revealed several 
classes of genes responding to injury, such as neuropeptides, signal transduction molecules, cell 
cytoskeletal components, and inflammatory mediators (Strickland et al., 2011). However, the 
mechanisms that are responsible for the global regulation in gene expressions remain largely 
unclear. 
One possible regulatory mechanism involved in nerve regeneration is controlled by 
miRNA pathway. miRNAs are short, non-coding RNAs that silence mRNA expression by 
imperfect binding to miRNA recognition elements in mRNA targets (Bartel, 2004, Filipowicz et 
al., 2008). Their ability to simultaneously regulate the expression of several genes suggests that 
miRNAs are potential regulators for complex transcriptional networks (Yu et al., 2011a, Yu et 
al., 2011c). In the nervous system, miRNAs have been linked to neurodevelopment (Smith et al., 
2010), neurogenesis (Shi et al., 2010), and neurological disorders (Hebert and De Strooper, 2007, 
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Kim et al., 2007). More recently, research established that a group of miRNAs reside within the 
distal axonal domain of superior cervical ganglia neuron (Natera-Naranjo et al., 2010). Further, 
changes in the expression of miRNA machinery in response to peripheral nerve lesion have also 
been reported (Wu et al., 2011a). Lastly, altered miRNA levels in DRG after sciatic nerve injury 
also suggested the contribution of miRNAs pathway in nerve regeneration (Yu et al., 2011a, 
Zhang et al., 2011).  
Recent studies in our lab showed the importance of miRNAs in peripheral nerve 
regeneration using an inducible Dicer knockout model. Blocking Dicer dependent miRNA 
biogenesis markedly delayed the regenerative axon growth in vivo and in vitro, giving an 
indication of the functions of miRNAs in then PNS (Wu et al., 2012).  In the current study, we 
investigated the role of individual miRNAs, which followed an injury-regulated expression 
pattern during peripheral axonal regeneration by in vitro functional analysis. Herein, we reported 
that miR-431, an injury-induced miRNA, promoted regenerative axon growth in DRG neurons. 
In addition, its potential target gene Kremen1 was validated experimentally. Kremen1 functions 
as a negative regulator of the Wnt signaling pathway. Our observations suggest that upregulation 
of miR-431 after nerve injury inhibits the expression of Kremen1, leading to the activation of 
Wnt pathway. Collectively, our observations provide additional evidence for a role for miRNA 





miRNAs are differentially expressed in DRG upon sciatic nerve injury 
We analyzed miRNA expressions in DRGs from CD1 mice using microarrays at 4 days 
after sciatic nerve crush. DRGs were collected from both the pre-conditioned side, as well as the 
contralateral uninjured side. RNA from the contralateral uninjured side served as a control group. 
At 4 days post-injury, pre-conditioned DRG neurons showed robust regenerative axon growth in 
previous studies (Forman et al., 1980). RNA from the pre-conditional DRG was considered the 
actively regenerating group. By comparing the miRNA expression profiles from preconditioned 
DRG and control DRG, miRNAs that were upregulated and downregulated during the process of 
regeneration were determined. Several miRNAs demonstrated differential expression based on 
regenerative growth condition. Using 1.5-fold cut-off, statistical analyses revealed that 19 
miRNA were differentially expressed in the pre-conditioned DRG compared to the non-
conditioned contralateral DRG. Of those 19, 11 miRNAs had higher expression level in pre-
conditioned group and the other 8 miRNAs had lower expression level in DRG during 
regeneration (Fig. 5.1A). miR-431, miR-714, miR-744, miR-877, miR-130b, miR-21, miR-323-
3p, miR-325, miR-409-3p, miR-154*, and miR-681were significantly increased 4 days post 
sciatic nerve crush in pre-conditioned DRGs, while miR-190, miR-1, miR-33, miR-32, miR-153, 
miR-335-5p, miR-193, and miR-488 showed significantly decreased expression.  
We validated the microarray data for miR-744, miR-431, and miR-21 using real time 
PCR. We also included miR-124 and miR-29a in our real time PCR experiments as  negative 
controls. These two miRNAs play various roles in neurodevelopment and maintenance of 
neuronal cell homeostasis; however they did not show changes in their expression in our array 
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data. In agreement with the microarray data, miR-744, miR-431, and miR-21 were significantly 
upregulated when the neuronal cells were regenerating. There was a 2 fold upregulation of miR-
744, 2.4 fold upregulation of miR-431, and 2.5 fold upregulation of miR-21, respectively (Fig. 
5.1B). Further, RT-qPCR experiments showed that miR-29a and miR-124 did not change in their 
expression. 
Optimization of transfection and silencing efficiencies 
We first optimized transfection of miRNA mimics and inhibitors into primary neuronal 
cell cultures with a FAM-conjugated scrambled miRNAs. Transfection efficiency of RNA 
molecules was above 90% as determined under immunofluorescence microscope (Fig. 5.2A and 
B). Since DRG neurons are considered ‘hard-to-transfect’ cells, the efficiency of transfected 
miRNA mimics/inhibitors to alter their target gene expression in DRG neuronal cells was also 
determined. As part of this process, we utilized miR-1, a well-established positive control, in our 
samples. miR-1 effectively downregulated the expression of twinfilin-1, also known as PTK9, at 
the mRNA level once cell transfection occurred. Based on the expression level of PTK9, we 
analyzed the efficiency of miRNA mimics and miRNA inhibitors in our neuronal cell cultures. 
The mRNA levels of the miR-1 target gene PTK9 were quantified by RT-qPCR analysis in five 
groups of cell cultures. Our data show that the negative control of miRNA mimics did not 
change the mRNA level of PTK9, whereas miR-1 mimic caused the destabilization of its target 
mRNA, leading to the significant decrease of the PTK9 mRNA level (Fig. 5.2B). By applying 
the miR-1 inhibitor, it salvaged the expression of PTK9 mRNA and prevented the miR-1 induced 
degradation of PTK9 mRNA. Conversely, the negative control of miRNA inhibitors has a 
scrambled nucleotide sequences. This prevented its binding to miR-1 and therefore, the mRNA 
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level of PTK9 in the last group was comparable to its level in miR-1 mimic treated group (Fig 
5.2C).  
miR-431 promotes neurite regenerative outgrowth  
To investigate the role of miR-431 in regenerative axon growth, we manipulated the level 
of miR-431 in dissociated DRG neurons. We observed a positive correlation between miR-431 
expression and neurite outgrowth in dissociated DRG neuronal cell culture (Fig. 5.3A). Increased 
mir-431 level was achieved by applying miR-431 mimic into DRG neuronal cell cultures at a 
final concentration of 100 nM. Overexpression of miR-431 significantly increased axon length. 
Additionally, blocking miR-431 activity by miR-431 inhibitor significantly inhibited neurite 
extension (no treatment control group: 100 ± 5%; miR-431 mimic group: 130 ± 6%; mimic 
negative group: 91 ± 4%; miR-431 inhibitor group: 75% ± 7%; inhibitor negative control: 90 ± 
8%) (Fig. 5.3A and B). Further, manipulating miRNA-431 levels also affected axon branching, 
and led to a decrease in the number of branches per neuron due to transfection of miR-431 
inhibitor (no treatment control group: 100 ± 9%; miR-431 mimic group: 110 ± 10%; mimic 
negative group: 82  ± 7%; miR-431 inhibitor group: 64% ± 6%; inhibitor negative control: 
86±10%) (Fig. 5.3A and C). 
We next studied GAP-43 expression in DRG neurons with miR-431 mimic and inhibitor 
treatments, as a strong correlation between neurite outgrowth and expression of Gap-43 has been 
reported in previous studies (Benowitz and Routtenberg, 1997). GAP-43 mRNA level was 
detected with RT-qPCR. Fig 5.3E clearly demonstrates a significant increase in GAP-43 mRNA 
in the cultures treated with 100 nM of miR-431 mimics, as compared to the group treated with 
the scrambled miRNA mimic control. This correlated with previous morphological data that 
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axon length was significantly higher after overexpression of miR-431. Furthermore, antibodies 
against GAP-43 were utilized to detect the expression of GAP-43 protein in DRG neuron. 
Immunofluorescent image showed that GAP-43 localized in both neuronal cell bodies and axons, 
and transient transfection of miR-431 mimics increased the signal intensity from the antibodies 
against GAP-43 (Fig 5.3A and D). Sequestration of miR-431 by the use of miR-431 inhibitors 
had the opposite effect. However, the decrease of the GAP-43 expression was not statistically 
significant. 
Kremen1 is a potential target of miR-431 
Bioinformatic prediction revealed a large number of potential miR-431 targets. We used 
two databases (http://www.targetscan.org and http://www.microrna.org) to generate a list of 
mRNAs with potential binding site for miR-431 in their 3’ UTR. The potential candidates were 
further selected based on evaluation of the gene expression profile of DRGs four days post 
sciatic nerve injury. We detected an increased expression of miR-431 in preconditioned DRG, 
suggesting that in the same RNA samples, the targets mRNAs of miR-431 should show 
decreased expression levels. Only 24 genes met both criteria, having conservative binding site 
for miR-431 in their 3’ UTR and down-regulated expression level in DRG after sciatic nerve 
injury. 
To investigate which genes may be regulated by miR-431, we applied miR-431 mimics to 
neuronal cells induced from PC12 cells and to DRG neurons. As shown in table 3, the mRNA 
expression of the 24 potential target genes were evaluated by RT-qPCR. CLIP experiments were 
performed to confirm the association of target genes with RISC. Employing the Western blotting 
analysis for proteins from DRG cultures with different treatments confirmed the correlation 
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between gene expressions and miRNA expression. Our experimental validation suggested 
Kremen1 as the target gene for miR-431.  
Kremen1 has one binding site for miR-431 at its 3’ UTR, at the position 2530-2536 bp. It 
corresponds perfectly to nucleotides 2-7 of the mature miRNA in mouse, rat, and human. In 
addition, the seed target site is close the poly-A tail, which increases its accessibility. To show 
that miR-431 regulates endogenous Kremen1 in DRG neurons, we transfected cells with miR-
431 mimics, miR-431 inhibitors, mimic negative control, or inhibitor negative control. In protein 
analysis, miR-431 reduced Kremen1 protein levels within DRG neurons, whereas when 
endogenous miR-431 was inhibited, the expression level of the Kremen1 protein was 
significantly higher than in negative control groups. Quantification of three independent 
experiments revealed that miR-431 reduced Kremen1 protein levels by 50% when compared 
with the mimic negative control group. On the other hand, inhibition of endogenous miR-431 
resulted in a significant increase of Kremen1 expression by 45% (Fig 5.4B and C).  
Since miRNA-mediated gene regulation can destabilize target mRNA and reduce the 
level of the target mRNA, we used RT-qPCR to determine the effect of miR-431 on Kremen1. 
Similar to what we observed on the protein level, when miR-431 level was up-regulated by 
transient transfection of miR-431 mimics, the mRNA level of Kremen1 went down 30% and 
when endogenous miR-431 was inhibited by miR-431 inhibitors, the mRNA level of Kremen1 
was significantly elevated (Fig 5.4A). These results demonstrated that miR-431 level is inversely 
correlated to Kremen1 expression at both protein and mRNA level in DRG neurons. 
To establish whether there is a direct interaction between Kremen1 mRNA and miR-431 
in the RNA-induced silencing complex (RISC), immunoprecipitation of the Ago2 protein, the 
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central component of the RISC was carried out. PCR was performed to quantify the level of 
Kremen1 mRNA presented in the total RNA and IP fractions from DRG cultures treated with 
miRNA mimic negative control and miR-431 mimic. miR-431 mimic increased the level of miR-
431 in DRG neuronal cell cultures (Fig. 5.4 D). In the total RNA samples from DRG cultures, 
overexpression of miR-431 reduced the amount of stable Kremen1 mRNA when compared to the 
miRNA mimic negative control group (Fig 5.4E). In the Ago2 immunoprecipitated RNA 
samples, overexpression of miR-431 obviously increased the level of Ago2 associated Kremen1 
mRNA (Fig 5.4E). Nonspecific mouse serum conjugated beads were used as a negative control, 
since they could not precipitate Ago2 and Ago2 associated RNAs. In this IP negative control 
group, no detectable Kremen1 mRNA was observed, confirming the specificity of the 
precipitation (Fig 5.4E). These data showed that in the miRNA mimic negative control groups, 
the amount of endogenous Kremen1 RNA associated with Ago2 was very low. When the 
abundance of miR-431 was elevated, the interaction between miR-431 and Kremen1 mRNA in 
RISC was enhanced. Therefore, the amount of Kremen1 in association with Ago2 increased after 
miR-431 mimics were transfected into DRG neurons. 
Together, these data suggest that miR-431 actively modulates Kremen1 protein and RNA 
expression within DRG neurons through association to Kremen1 mRNA in RISC. 
Kremen1 expression in DRG in vivo 
After establishing a relationship between miR-431 and Kremen1, we next investigated the 
expression patterns of Kremen1 during nerve regeneration. From gene expression array data, 
Kremen1 expression in DRG decreased at 4 days after sciatic nerve injury, suggesting its 
expression was downregulated as peripheral nerve regenerated. To further confirm the functional 
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relationship between miR-431 and Kremen1, we collected DRGs 4 days after sciatic nerve 
injury, as we did prior for microarray analysis. We analyzed RNA and protein from control and 
injured mouse DRGs. RT-qPCR revealed that Kremen1 RNA expression decreased 4 folds at 4 
days after nerve crush when regenerative axon growth was taking place (Fig. 5.5A). Similarly, 
we found that Kremen1 protein was reduced in DRG 4 days post injury. The Western blot data 
showed a significant 80% decrease in Kremen1 expression after sciatic nerve injury when 
compared to control (Fig.5.5B).  
The expression of Kremen1 in DRG neuron was further examined in vitro. 
Immunostaining with antibodies against Kremen1 revealed the localization of Kremen1 in 
dissociated DRG neurons. In both preconditioned and control groups, the immunoreactivity of 
Kremen1 was detected mainly in neuronal cell bodies, but there was less Kremen1 
immunostaining in the preconditioned group (Fig. 5.5C). The data further supported a functional 
relationship between miR-431 and Kremen1 in regenerating DRG neurons and implicated the 
role of Kremen1 in peripheral nerve regeneration. 
Functional analysis for Kremen1 
Given the effects of miR-431 on Kremen1 expression and the role of miR-431 in neurite 
outgrowth, the effect of downregulating Kremen1 expression on regenerative axon growth was 
investigated. Two groups of DRG neurons were culture in vitro. One group was transfected with 
siRNA specifically targeting Kremen1 mRNA, which inhibit Kremen1 expression in DRG 
neurons. A negative scrambled siRNA was transfected to the other group of DRG cultures to 
control for any nonspecific effects of transfection. The differences in the regenerative growth 
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between Kremen1 siRNA group and control scrambled siRNA groups were specifically resulted 
from the knock down of Kremen1 expression in neuronal cells. 
From the quantified data shown in Fig. 5.6B and C, knockdown of Kremen1 significantly 
changed axon length, but not the number of axon branches in dissociated DRG culture. The axon 
length in the Kremen1 knockdown group increased 30% in comparison to the scrambled siRNA 
control group. This effect on axon outgrowth is similar to miR-431 overexpression on axon 





Figure 5.1. Sciatic nerve injury induced changes in miRNA expression profile in DRG 
(A) Total RNA for the microarray expression analysis was isolated from DRG 4 days after 
sciatic nerve crush. Agilent arrays were done in duplicates and repeated twice. Normalization 
and analyses were performed with GeneSpring software. miRNAs with a statistically significant 
upregulation or downregulation over 1.5 fold were listed in the table. (B) Three miRNAs that 
were significantly upregulated were selected for further validation. Real-time qPCR for miRNA 
validated the relative changes in miRNA level. miRNA expression was normalized to reference 
gene s12. The graph indicates a significant increase of miR-744, miR-431 and miR-21 in DRG 
after sciatic nerve crush, whereas the expression level of miR-124 and miR 29a didn’t change. (* 








Figure 5.2. Transfection efficiency and silencing efficiency in functional analysis assay 
RNA transfection efficiency was above 90% as determined using a fluorochrome-conjugated 
scrambled miRNA. (A) After culturing dissociated DRG neurons for 24h, neuronal somas and 
axons were visualized under a bright field. (B) FAM-conjugated scrambled miRNAs were 
observed within the neuronal cell body, indicating successful transfection of miRNAs into cells. 
Scale bar = 50 µm. (C) miR-1 mimics and inhibitors were used to test silencing efficiency of 
miRNA mimics and inhibitors by RT-qPCR in our studies. miR-1 was chosen as a positive 
control, since upon delivery into cells, it effectively down regulates the expression of twinfilin-1, 
also known as PTK9, at the mRNA level. Dissociated DRG culture without any treatment served 
as the control group. Pre-miR™ hsa-miR-1 miRNA precursors, short as miR-1 mimics, were 
transfected into dissociated DRGs and successfully suppressed the expression of PTK9 as shown 
in column 2. Pre-miR negative controls are random sequences of miRNA mimic molecules that 
have been validated not to produce identifiable effects on known miRNA function. Transfection 
of miRNA mimic negative controls did not cause significant change in PTK mRNA levels when 
comparing column 1 with column 3. Use of the Anti-miR miRNA-1 inhibitors significantly 
down regulated the inhibitory activity of miRNA-1, based on the expression of PTK9 in column 
4. Anti-miR™ miRNA Inhibitor Negative Controls, short as miRNA inhibitor negative control, 
did not produce any effect on the function of miR-1 mimics, and there is significant change in 








Figure 5.3. miR-431 increases neurite outgrowth in DRG neurons. 
(A) Cell cultures were incubated with antibodies against neuronal β-tubulin and signals were 
visualized with TX-conjugated secondary antibody (Scare bar = 50 um). The expression of GAP-
43 was detected using an anti-GAP-43 antibody. GAP-43 is expressed in both cell bodies and 
axons, but more highly in cell bodies. The effect of miR-431 on axon length (B) and on axon 
branching (C) was also quantified. Overexpression of miR-431 significantly increased axon 
extension, whereas suppression of miR-431 significantly blocked axon branching. The 
fluorescence signal intensity against GAP-43 was quantified in (D). (E) RNA from DRG cultures 
treated respectively with miR-431 mimics, mimic negative control, miR-431 inhibitor, or 
inhibitor negative control were collected. GAP-43 expression on mRNA level was quantified by 
RT-qPCR. GAP-43 expression correlated well between mRNA level and protein level. Over 
expression of miR-431 enhanced the expression of GAP-43, the regeneration marker for neurons. 








Table 5.1. Relative expression of miR-431 potential target genes 
24 genes meet the criteria of having conservative binding site for miR-431 in their 3’ UTR and 
down-regulated expression level in DRG after sciatic nerve injury. Changes in the expressions of 
these 24 genes in response to elevated miR-431 level were examined in neuron cells derived 
from PC12 cells. In the table, the values represent the relative expression levels of each gene 
after the application of miR-431 mimics. Colum 1 shows that 8 out of 24 potential target genes 
showed down regulated expression in PC12 cells after applying miR-431 mimics. Colum 2 









Figure 5.4. miR-431 regulates Kremen1 expression 
(A) miR-431 negatively regulated Kremen1 expression at mRNA level. Treatment of miR-431 
mimics in DRG neuronal cultures significantly inhibited Kremen1 expression as compared with 
that of control groups. On the contrary, suppression of miR-431 activity significantly enhanced 
the expression of Kremen1 mRNA. (B) Western blot analysis of Kremen1 expression exhibited 
similar negative correlation of miR-431 and Kremen1 expression. Cells transfected with miR-
431 mimics had decreased protein level of Kremen1, whiles cells transfected with miR-431 
inhibitors had an increased expression of Kremen1. α-tubulin was used as the loading control and 
was used to normalize densitometry values. The quantification of Kremen1 protein levels is 
shown in (C). (D). RT-qPCR confirmed the increase of miR-431 level in DRG neuron after the 
transfection of miR-431 mimic. (E) Although overexpression of miR-431 decreased Kremen1 
mRNA in total cell lysates (input), it enhanced the binding between Kremen1 mRNA and Ago2 
complex. In the Ago immunoprecipitated fractions, there was an increased amount of Kremen1 














Figure 5.5. Nerve crush injury reduces Kremen1 expression 
(A) Total RNA was isolated from control or crush-injured mouse DRG, and relative expression 
of Kremen1 was determined using RT-qPCR. GAPDH and S12 were used to normalize for RNA 
loading. (B)  Western blot analysis of total DRG lysates at 4 days post crush injury. α-tublulin 
was shown as a loading control. As shown in the quantified densitometry data, there was a 
significant decrease of Kremen1 expression during nerve regeneration. (C) Immunofluorescent 
staining in dissociated DRG neurons demonstrated the expression of Kremen1 within neurons. 
Kremen1 as a transmembrane receptor was shown to be located in cell bodies, but not axons. 
TUJ staining was used to visualize neuronal cells. Preconditioning of sciatic nerve obviously 
promotes regenerative axon growth in DRG neurons, and this phenomenon is accompanied by a 








Figure 5.6. Knockdown of Kremen1 increases neurite outgrowth. 
Neurite outgrowth in Kremen1 siRNA and scrambled siRNA treated DRG neurons was detected 
by TUJ immunostaining (A) Representative images show that Kremen1 siRNA significantly 
decreased Kremen1 expression level, which was accompanied by an increase of axon outgrowth. 
Scale bar = 20 um. As the quantification performed in miR-431 functional analysis, we measured 
the length of the longest axon for each neuron (B) and counted the number of branches for each 
neuron (C). Inhibition of Kremen1 significantly increased the length of axon, however its effect 









Neurons of the peripheral nervous system have the intrinsic capacity to regenerate 
following injury. Previous studies on the molecular mechanisms that contribute to peripheral 
nerve regeneration have demonstrated that an alteration of gene expression in neurons, initiated 
by nerve injury, promotes neuronal cell survival and axonal regeneration (Hoffman, 2010). 
Further, the regulation of gene expression can take place at both transcriptional and post-
transcriptional levels. While the regulation of transcriptional change through injury induced 
activation of transcription factors, such as c-Jun and ATF-3, has been widely studied, the 
understanding of post-transcriptional regulation of gene expression following nerve injury is just 
emerging (Broude et al., 1997, Tsujino et al., 2000, Hyatt Sachs et al., 2007, Dahlin et al., 2009).   
In the present study, an in vitro model system was used to gain insight regarding the role 
of miRNAs in regenerative axon growth. Microarray analysis demonstrated that there are 
changes in the expression of a set of miRNAs following sciatic nerve injury in adult mouse 
DRG. One of the injury induced miRNA, miR-431, enhanced neurite outgrowth in dissociated 
mouse DRG neurons in our in vitro functional analysis. Using biochemical and molecular 
approaches, we have identified Kremen1 as a target gene regulated by miR-431 in DRG cultures. 
In DRG neurons 4 days post sciatic nerve injury, Kremen1 had decreased expression levels. 
Considering Kremen1 functions as a gatekeeper for the Wnt pathway, this raised the possibility 
that overexpression of miR-431 after nerve injury inhibits Kremen1 expression, leading to the 
activation of the Wnt pathway, which subsequently promotes regenerative axon growth. 
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Altered miRNA expression following sciatic nerve injury in mouse DRG 
Our studies profiled the miRNA expression in DRG tissues 4 days post sciatic nerve 
injury in mice.  In our data, 19 miRNAs exhibited significant changes in expression levels after 
sciatic nerve injury in DRG, with 11 miRNA significantly upregulated and 8 miRNA 
significantly downregulated. Similar studies profiling miRNA expression after nerve injuries 
have been carried out before, however, most of the studies focused on injuries in central nervous 
system. Alteration in temporal expression of miRNA following a contusive spinal cord injury in 
adult rats has been recently shown (Liu et al., 2009). In the injured spinal cord 4 h, 1 day and 7 
days after acute SCI, 60 miRNAs showed significant changes in their expression level. Among 
those 60 miRNAs, 30 were up-regulated, 16 were down-regulated, and 14 showed early up-
regulation at 4 hour followed by down-regulation at 1 and 7 days post-SCI (Liu et al., 2009). 
Microarray based analysis of miRNA in the rat cerebral cortex after traumatic brain injury 
revealed that a set of miRNAs were differentially express at 6 hours, 24 hours, 48 hours and 72 
hours after injury. At all time points post injury, miR-21was consistently highly expressed in the 
cerebral cortex (Lei et al., 2009). Changes in miRNA expression in hippocampus after traumatic 
brain injury has also been studied by microarray analysis. Three and 24 hours after controlled 
cortical impact injury, 35 miRNA exhibited increased expression levels and 50 miRNA exhibited 
decreased expression level (Redell et al., 2009).   
In the last year, miRNA expression following sciatic nerve injury in proximal stumps of 
injured sciatic nerve and in DRG has been profiled by microarray approaches and deep 
sequencing in several studies (Strickland et al., 2011, Yu et al., 2011b). In DRG tissues, 19 
miRNAs showed significant changes at four early time points after sciatic nerve transaction. 
Notably, miR-188 was significantly upregulated at most time points. In contrast, miR-500 was 
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downregulated at most time points, but their functions remain largely unclear (Zhou et al., 2011). 
At 1, 4, 7, and 14 days after resection of the sciatic nerve in rats, 32 significantly upregulated and 
18 downregulated miRNAs were identified in the DRG at four time points following sciatic 
nerve injury (Yu et al., 2011a). A more recent study showed that 20 miRNA transcripts displayed 
a significant change in expression levels at 7 day post-axotomy in rat DRG following sciatic 
nerve transection, with 8 miRNAs that were regulated more than 1.5 fold (Strickland et al., 
2011). By comparing Strickland’s data with ours, one interesting observation occurred. miR-21 
and miR-431 have shown upregulation in DRG after sciatic nerve injury in both Strickland 
studies and our studies, suggesting these two miRNAs are constantly upregulated across species 
during nerve regeneration.  
While these studies suggest the involvement of miRNA regulation after nerve injury, to 
understand the underlying mechanism and physiological relevance of the changes, additional 
studies are required to investigate the function and targets of these miRNAs. 
Mir-21 is one of the most intensively studied miRNAs. It is one of the most highly 
upregulated miRNAs in cancers and cardiovascular disease, suggesting it has a fundamental role 
in cell growth and anti-apoptosis (Sayed et al., 2008, Feng et al., 2011). In Strickland’s studies, 
miR-21 was not only persistently upregulated after sciatic nerve injury, but also promoted the 
intrinsic growth capacity of the injured neuron. According to Strickland, the observed promotion 
of axon regeneration by mir-21 was possibly mediated through the knocking down of SPRY2 
(Strickland et al., 2011). 
Our studies focused on miR-431. miR-431 has been identified in embryonic and postnatal 
mouse brains, it was evenly expressed between E13 and P10, especially strong in the Pons, but 
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accumulated at a much lower level in the adult brain (Wheeler et al., 2006). The Pons is 
particularly rich in synapses. Ninety percent of the descending axons passing through the 
midbrain synapse on neurons in the Pons, however the role of this miRNA in the nervous system 
has not yet been established. The only functional analysis of miR-431 investigated its role in cell 
viability in HuIFN-β sensitive cell line RSa and HuIFN- β resistant cell line, F-IFr cell lines. In 
RSa cells, miR-431 downregulates the expression of IGFIR and IRS2 at protein level, which 
subsequently modulates the activity of MAPK pathways (Tanaka et al., 2012).  
Of all other miRNAs that were upregulated in our array data, only miR-323-3p and miR-
681 were proved to be functional in neuronal cells. miR-323-3p is related to the pathology of 
Alzheimer’s disease (AD). AD may result from amyloid precursor protein (APP) expression 
misregulation. miR-323-3p can regulate APP expression in vitro and under physiological 
conditions in cells (Delay et al., 2011). miR-323-3p can also target the 3’ UTR of human FMR1, 
whose gene product FMRP is involved RNAi machinery, and a downregulation of FMRP leads 
to the expression of fragile X syndrome (Siomi et al., 2004, Yi et al., 2010). Another miRNA, 
miR-681, is predominantly localized in the hippocampus. Its expression level is up-regulated in 
long-lived mutant mice. These long-lived mutant mice exhibit heightened cognitive robustness 
and altered IGF1 signaling in the brain. miR-681 significantly reduced IGF1R expression, which 
is the key IGF1 signaling gene (Liang et al., 2011).   
Other miRNAs showed enhanced expression during nerve regeneration, but have no 
clearly identified functions within the nervous system. Functional analysis of miR-744 revealed 
that miR-744 targets the predominant, short, isoform of transforming growth factor beta-1 (TRG-
β1) 3’ UTR in epithelial cell line. TGF- β1 is a cytokine that plays various roles in healing and 
inflammation of wounds (Martin et al., 2011). miR-130b was validated to be elevated in plasma 
146 
 
from severe pre-eclamptic pregnancies (Wu et al., 2011b). Loss of miR-130b expression 
contributes to the generation of drug resistance in ovarian cancer (Yang et al., 2012). miR-409-
3p was significantly downregualted in gastric cancer cell lines. In addition, tissue and function 
analysis showed that overexpression of miR-409-3p in cancer cells dramatically suppressed cell 
proliferation and induced cell apoptosis through inhibiting transcriptional regulator PHF 10 (Li et 
al., 2012). In contrast rmiR-154* was upregulated in acute myeloid leukemia, which functions as 
a potential oncogenic miRNA (Dixon-McIver et al., 2008).  
The role of miR-431 in regenerative axon growth 
To define the role of miR-431 in regenerative axon growth, the effect of modulating miR-
431 level in neuronal cell was investigated in dissociated DRG neuron cultures. Expression of 
miR-431 mimics substantially increased the intracellular miR-431 activities and promoted 
regenerative neurite outgrowth. Morphological evidences correlated with the measurement of the 
expression of nerve regeneration marker GAP-43. Overexpression of miR-431 correlated with 
longer axons, more branches, and high GAP-43 expression. In contract, inhibition of miR-431 
activity by transfection of miR-431 inhibitors impaired the regenerative axon growth, as shorter 
axons and fewer branches were observed in DRG cultures. 
Since miRNAs execute their functions through inhibiting the expression of their target 
genes, we employed both bioinformatics and experimental approaches to identify the target gene 
by which miR-431 promotes axon growth. Our data identified Kremen1 as a target that mediates 
the effects of miR-431 on neuronal cells. We showed that miR-431 expression inversely 
correlates with Kremen1. The binding between miR-431 and Kremen1 mRNA was validated by 
co-immunoprecipitating Ago2 associated RNA. Upregulation of intracellular miR-431 level 
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enhanced the association of Kremen1 mRNA with Ago2 containing complex. Consistent with 
our in vitro study, increase of miR-431 after sciatic nerve crush accompanied the decrease of 
Kremen1 expression at both protein and mRNA in vivo. 
Kremen1 was originally discovered as a transmembrane protein containing the kringle 
domain. Later reports confirmed that both Kremen1 and its relative Kremen2 were high-affinity 
receptors for Dickkopf1 (Dkk1), the inhibitor of Wnt/β-catenin signaling (Mao et al., 2002). The 
canonical Wnt/ β-catenin signaling is mediated by two receptor families, Frizzle protein and 
Lipoprotein-receptor-related protein 5 and 6 (LRP5/6). Kremen1 functionally cooperates with 
Dkk1 to form a ternary complex composed of Kremen1, Dkk1, and Lrp5/6, and induces rapid 
endocytosis and removal of the Wnt receptor LRP5/6 from the cell membrane, which inhibits the 
transduction of Wnt/ β-catenin signaling (Fig 5.7).  
Wnt/β-catenin signaling plays a vital role in diverse developmental and physiological 
processes, including cell-fate determination, tissue patterning and stem cell regulation (Diep et 
al., 2004). Kremen1 is quite significant in these processes as a mechanism to regulate Wnt/β-
catenin signaling. The transcription factor β-catenin can induce proliferation of undifferentiated 
precursor cells rather than differentiation (Brembeck et al., 2006). Other studies have shown that 
Kremen1 expression gradually and continuously increases with developmental progression and 
cell differentiation (Nakamura and Matsumoto, 2008). Since Wnt/ β-catenin signaling maintains 
stem cells and precursor cells in a pluripotent state and maintains their self-renew, increased 
expression of Kremen1 is likely to initiate cells into the path of differentiation through turning 
off Wnt/ β-catenin signaling (Scholzke and Schwaninger, 2007). 
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Wnt/ β-catenin signaling pathway also contributes to adult neurogenesis. Blocking Wnt 
signaling suppresses neurogenesis from adult hippocampal progenitor cells in vitro and abolishes 
neurogenesis almost completely in vivo (Lie et al., 2005). With ectopic expression of Dkk1, 
canonical Wnt/ β-catenin signaling is reduced in both the hippocampus and cortex. As a result, 
the cell cycle of neurogenic progenitor cells extended and proliferation of cells reduced, 
therefore, reducing the hippocampal field in size (Solberg et al., 2008). Recent studies have 
shown that the inhibition of Wnt/ β-catenin depletes the pool of multipotent progenitors from the 
adult hippocampal progenitor cells population (Wexler et al., 2009). 
Studies have also established a role for Wnt signaling in regulating synaptic plasticity and 
axonal growth (Hall et al., 2000, Wang et al., 2006, Budnik and Salinas, 2011). Wnt signaling 
regulates axon terminal remodeling (Budnik and Salinas, 2011), formation of growth cones and 
lamellipodia (Hall et al., 2000), microtubules organization (Purro et al., 2008), and synaptic 
assembly (Ahmad-Annuar et al., 2006). Loss and gain of function studies in animal models 
demonstrated that loss of Wnt7a results in a strong deficit in the accumulation of synaptic 
markers at the cell synapses (Ahmad-Annuar et al., 2006). In contrast, in cultured mouse 
cerebellar granule cells, Wnt7a increased neurite spreading and branching as well as the 
expression of synaptic markers (Lucas and Salinas, 1997). Likewise, targeted disruption of Wnt 
receptor genes in mice produced severe defects in axon growth and guidance, resulting in loss of 
thalamocortical, nigrostriatal tracts and the anterior commissure (Wang et al., 2002a, Wang et 
al., 2006).  
Wnt not only modulates the synapse formation but also promotes the remodeling of 
mature terminals elicited by changes in electrical activity and environmental experience (Budnik 
and Salinas, 2011). Chemically or electrically induced neuronal activity stimulates the 
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expression of Wnt proteins (Wayman et al., 2006). NMDA receptor activation in hippocampal 
neurons promotes dendritic arborization through increase expression of Wnt2 (Wayman et al., 
2006). High frequency stimulation in hippocampal neurons can induce long-term potentiation, 
activate the Wnt signaling pathway, and promote synapse formation (Sahores et al., 2010), 
whereas blocking of Wnt signaling impairs long-term potentiation in brain slice (Chen et al., 
2006). Moreover, spinal cord injury induced a time-dependent increase in Wnt expression, 
phosphorylation of Wnt receptors, and activity of β-catenin protein. The activation of the Wnt 
pathway after spinal cord injury suggests the involvement of Wnt pathway in nerve regeneration 
(Fernandez-Martos et al., 2011).  
These abundant evidences from studies in animal models, cell and organ culture firmly 
established an important role of Wnt signaling in neurite outgrowth and axonal guidance. The 
function of Wnt signaling could potentially link our observation of increased miR-431 and 
decreased Kremen1 expression to the enhanced axonal outgrowth. Furthermore, siRNA mediated 
downregulation of Kremen1 had a similar positive effect on neurite outgrowth as upregulation of 
miR-431, though the effect was less profound. Since each miRNA has multiple targets, the 
effects of miR-431 on regenerative axon growth are likely to be mediated through Kremen1 as 
wells as other unidentified targets. It will be interesting to determine these unidentified targets of 
miR-431 in DRG neurons in the future and identify the function of miR-431 targets in the DRG.  
Taken together, our studies identified miR-431 as an endogenous, injury-regulated 
inhibitor of Kremen1 which promotes regenerative axon growth. Increased miR-431 level 
enhanced axon elongation and branching possibly through activation of Wnt pathway. This study 
further confirmed that miRNAs play a critical role for peripheral nerve regeneration. Injury 
induced miRNAs may be beneficial for DRG neurons during the process of regeneration. Further 
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studies are necessary to fully define the role of miR-431 in axonal regeneration. These findings 
may not only contribute to our understanding of fundamental biological process, but also could 




Figure 5.7 Kremen1 functions as gatekeeper for Wnt pathway 
Kremen1 is a transmembrane high-affinity receptor for Dickkopf1 (Dkk1), the inhibitor of 
Wnt/β-catenin signaling. Under normal physiological condition, Kremen1 functionally cooperate 
with Dkk1 to form a ternary complex composed of Kremen1, Dkk1, and Lrp5/6, and induces 
rapid endocytosis and removal of the Wnt receptor LRP5/6 from the cell membrane, which 
inhibits the transduction of Wnt/ β-catenin signaling (left picture). When Kremen1’s expression 
is suppressed, Wnt binds to its two receptor families, Frizzle protein and Lipoprotein-receptor-
related protein 5 and 6 (LRP5/6), which prevent the phosphorylation and degradation of β-








CHAPTER VI: General Discussion 
The mechanism of post-translational regulation of gene expression by small RNAs was 
first identified in C. elegans in 1998 (Fire et al., 1998). As one of the major discoveries in the 
history of molecular and cell biology, it has become a major focus of research in the last decade. 
Currently, over two dozen distinct families of noncoding RNAs have been discovered and the 
number continues to increase. Within the RNA family, miRNAs remain the most prominent 
family member of small RNA (Burian, 2007). miRNAs are encoded within the genome, however 
their sequences are not translated into protein, but bind to matching endogenous messenger 
RNAs and silence their expressions (Filipowicz et al., 2008). The understanding of miRNA 
pathway in neuroscience is growing at a rapid pace through intensive investigation of a variety of 
neurological events. Temporally and spatially specific miRNA expression has been identified in 
neurodevelopment and in neurological disease (Martino et al., 2009, Smith et al., 2010, Martins 
et al., 2011).  
Although the miRNA machinery has been shown to be present in axonal compartments 
and are functional upon application of siRNA to peripheral nerve fibers (Hengst et al., 2006, 
Murashov et al., 2007), it is unclear if it can actively regulate local mRNA translation after 
peripheral nerve injury. To answer this intriguing question, the current study investigated the role 
of miRNA pathway in peripheral nerve regeneration following sciatic nerve crush. Sciatic nerve 
crush is a well-established model for regeneration studies, comprising a mixed population of 
motor and sensory axons, and studies on sciatic nerve regeneration have helped to identify many 




the sciatic nerve crush model to elucidate the significance of miRNA pathway in regenerative 
axon growth.  
Initially, we inquired about the involvement of the miRNA biosynthetic machinery in the 
regulation of intra-axonal local protein synthesis after injury. Previous studies in our lab have 
shown the existence of protein components of RISC in sciatic nerves. Transfection of siRNA 
against neuronal β-tubulin into axons initiated the formation of RISC and the suppressions of 
target genes (Murashov et al., 2007). In the current study, we hypothesized that there is an 
injury-regulated expression of biosynthetic enzymes, including components of RISC and P-
bodies. The expressions of the corresponding enzymes were tested by immunoblotting and 
immunofluorescence analyses. We detected changes in the expression of miRNA machinery 
components in protein lysates from injured sciatic nerves. Their expression in the subcellular 
axon region was observed by immunofluorescence staining in dissociated DRG culture. An 
increase in the number and the size of P-bodies, the site for either degrading or sequestering 
mRNA, was observed in the regenerating axons. While the importance of local protein synthesis 
for nerve regeneration has been shown by an increase in local translation of proteins after 
peripheral nerve axotomy and the observation that inhibiting this synthesis greatly reduces the 
reproduction of growth cones (Verma et al., 2005), the underlying mechanism responsible for the 
regulation of the local protein synthesis is largely unknown. Our data suggests that miRNA could 
be one of the potential mechanisms that regulate axonal protein synthesis after peripheral nerve 
injury. This hypothesis is supported by the recent discovery of 130 miRNAs located at the distal 
axon area (Natera-Naranjo et al., 2010). 
In addition, a group of miRNAs that are specifically expressed in an injury-regulated 
pattern in the regenerating sciatic nerves were identified by miRNA microarrays and confirmed 
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by qPCR. The most upregulated miRNA, miR-21 has shown the ability to promote axon growth 
in adult DRG neurons through targeting SPRY2 (Strickland et al., 2011). Overexpression of 
miR-21 also protects against ischemic neuronal death, probably mediated by its downregulation 
of FASLG, an important cell death-inducing ligand (Buller et al., 2010). The upregulated miR-
29b exhibited neuronal protective effects (Kole et al., 2011). It was shown that miR-29b 
functions as a novel inhibitor of neuronal apoptosis by targeting multiple proapoptotic BH3-3 
only gene family (Kole et al., 2011). Some of the upregulated miRNAs have injury-induced 
expression patterns in CNS as well, such as miR-211 and miR-142-5P. Their expression levels 
were increased after brain injury or spinal injury, respectively (Lei et al., 2009, Liu et al., 2009). 
The downregulated miRNA, miR-145, has been shown to inhibit neurite outgrowth in vitro with 
robo2 and srGAP2 validated as its potential target genes (Zhang et al., 2011). Surprisingly, some 
miRNAs showed a decrease in their expression level in our sciatic nerve microarray analysis 
correlating with a positive effect on axon outgrowth, such as miR-124a and miR-133. miR-124a 
decreased its level in sciatic nerves after crush, however it was required for hippocampal 
axogensis through Lhx2 suppression, which also prevents apoptosis in the developing retina 
(Sanuki et al., 2011). In zebrafish, miR-133 has been shown to promote tissue regeneration by 
targeting an inhibitor of axonal growth, the small GTPase RhoA (Yu et al., 2011c). Since the 
sciatic nerve is a heterogeneous tissue, the changes in miRNA expression profile may result from 
responses of Schwann cells as well as neuronal cells to nerve injury. This may partially explain 
why some of our array data did not correlate very well with the functions of the miRNA in 
neuronal cells. Thus, in the later studies, we performed microarray analyses in RNA samples 
isolated from DRG following sciatic nerve crush, whose cell population is primarily neuronal 
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cells. Only miR-21 was upregulated in both array data, which further confirmed the spatial 
specificity in miRNA expression. 
While the first part of the study demonstrates the response of miRNA biogenesis to 
injury, the physiological significance of it was elucidated in the second part of the study. We 
used the approach of ablating the miRNA processing enzymes Dicer, causing a deduction of all 
miRNA production. In early studies, miRNA formation was interrupted at its proximal step by 
ablation of the components of Drosha, the enzymes responsible for processing primary miRNA 
into precursor miRNA intranuclearly (Rao et al., 2009). Recent studies observed an alternative 
origin of miRNA, which clustered at the outer edge of short introns. They are being processed 
into precursor miRNA by splicing, rather than depending on Drosha cleavage. The discovery of 
the non-classical splicing-dependent miRNA biogenesis pathway suggest Dicer knockout could 
be a better approach to block miRNA biogenesis, because both classical miRNA pathway and 
the non-classical miRNA pathway need the nuclease Dicer to process precursor miRNA into 
mature miRNA (Sibley et al., 2012). In the second part of the study, we hypothesize that the 
deletion of Dicer would disrupt production of Dicer-dependent small RNAs and would 
negatively impact peripheral nerve regeneration. Taking advantage of tamoxifen-inducible CAG-
CreERt:Dicer
fl/fl
 knockout mice (Dicer knockout), we examined the effect of blocking Dicer-
dependent miRNA pathway on peripheral nerve regeneration in vivo and regenerative axon 
growth in vitro. Peripheral nerve regeneration after sciatic nerve injury was studied in vivo using 
functional behavioral tests and electrophysiology analyses. Restoration of motor and sensory 
function was markedly impaired by Dicer deletion. Further, Dicer deletion impeded the recovery 
of nerve conduction velocity and amplitude of evoked compound action potentials. 
Corresponding to our functional data, we found that at the histological level the total number of 
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regenerating nerve fibers and mean axonal area of myelinated fibers in Dicer knockout mice was 
notably smaller in comparison with control mice. In addition, the regenerative axonal growth 
was impeded by Dicer knockout in dissociated neuronal cultures from DRG neurons. 
Our data provide an insight on the significance of Dicer-dependent miRNA pathway in 
regulation of regenerative axon growth, however it revealed little about the mechanisms of how 
miRNA contributes to regenerative axon growth. To better address this issue, we performed 
functional analyses for miRNAs that are upregulated during nerve regeneration. Since blocking 
miRNA would impede regenerative axon growth, we speculated that one or more of the miRNAs 
whose expression are induced by injury are necessary for normal nerve regeneration. Our 
miRNA array data revealed a group of miRNAs differentially expressed during peripheral nerve 
regeneration. We focused our studies on the miRNAs whose expression level were significantly 
higher after nerve injury. The significance of each miRNA was tested experimentally by 
evaluating the length of axons and number of branches per neuron, and miR-431 exhibited its 
effect by promoting neurite growth in adult DRG neurons. Since miRNAs function through 
inhibiting gene expression, it was also necessary to find out the target genes for the miR-431. In 
DRG neurons, we observed miR-431 induced knockdown of Kremen1, a gatekeeper for the Wnt 
pathway (Wang et al., 2008b). We further confirmed the binding between miR-431 and Kremen1 
in RISC with immunoprecipitation assays. Furthermore, with an increased expression of miR-
431 in DRG after sciatic nerve crush, we detected a decreased expression of Kremen1 in DRG 
tissue in vivo. Silencing Kremen1 expression with an siRNA induced axon outgrowth, similar to 
overexpression of miR-431. Based on these observations, we postulated that the functional 
significance of injury-induced miR-431 is mediated through modulating Kremen1 protein level.  
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Overall, our data provide an insight into the role of miRNA pathway in the regulation of 
regenerative axon growth and shed light on the mechanism of miR-431 induced neurite 
outgrowth. It appears clear that miRNAs are important players in the complex regulatory 
network that modulate axonal regeneration. Further work will be required to elucidate how 
miRNA pathway contributes to peripheral nerve regeneration and how to use it as a tool to treat 
nerve injuries.  
Future Studies 
Future studies must be conducted to further characterize the mechanism for miRNA-
enhanced neurite out growth. Our data suggest that miR-431 promotes regenerative axon growth 
by suppressing the inhibition of Wnt pathway. To confirm this hypothesis, the activation of Wnt 
signaling must be investigated. We know that in the absence of Wnt stimulation, the Axin-based 
complex facilitates the phosphorylation of β-catenin, which targets them for rapid proteosomal 
degradation. Alternatively, activation of Wnt pathway dissociates the β-catenin degradation 
complex, resulting in the accumulation of β-catenin, which leads to its association with DNA-
binding proteins in nucleus and turning on the expression of Wnt target genes (Endo and Rubin, 
2007). To test if Kremen1 specifically inhibits Wnt pathway in DRG and downregulation of 
Kremen1 by miR-431 increases Wnt/β-catenin signaling, it will be necessary to test β-catenin’s 
protein level and phosphorylation level in DRG neurons with overexpression of miR-431.  
Also, it is unlikely that Kremen1 is the only target of miR-431 in DRG neurons, since 
each miRNA has multiple target genes. Identification of further miR-431 target genes will help 
us to reveal other unidentified pathways by which miR-431 promotes axonal regeneration. In 
addition, until recently, limited information has been available regarding mechanisms 
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modulating miRNA expression. miRNA genes are usually transcribed by RNA polymerase II, 
and a novel RNA polymerase III regulated transcription of miRNAs has been determined too 
(Borchert et al., 2006). Transcription factors are also involved in the regulation of miRNA 
expression. Some miRNA are repressed by the RE1 induced silencing factor (REST) in non-
neuronal cells. When REST-mediated repression of miRNA transcription was relieved, a 
neuronal phenotype was promoted (Conaco et al., 2006). Thus, understanding the regulatory 
mechanisms of miRNA expression will help us to further define the role of miR-431 in 
regenerative axon growth. The mechanisms through which neurons regulate expression of miR-
431 after nerve injury are currently unknown. miR-431 is located in chromosome 12 in the 
mouse and chromosome 14 in humans (Altuvia et al., 2005). Its antisense locates in the exon of 
RTL1 gene, which is an imprinted gene with preferential expression from the paternal allele, and 
is related to multiple organ developments (Davis et al., 2005). miR-431, miR-433 and miR-127 
are clustered across species. The distance between miR-433 and miR-127 across species was 
always between 986 and 1007 bp, and the position of transcription factor binding motifs in miR-
433/127 locus from mouse, rat, dog, and human was strikingly similar, suggesting a conserved 
gene structure and transcriptional regulation of this locus (Song and Wang, 2009).  
More importantly, all the functional analyses for miRNAs in our studies were performed 
in DRG neuronal cell cultures in vitro. Functional analysis for miR-431 in vivo would be the next 
step in our studies. Lentiviruses, adenoviruses, and adeno-associated viruses can be utilized for 
delivering small RNAs to the nervous system. Adenoviruses expressing shRNAs targeting 
transgenic eGFP has been successfully delivered to the mouse brain (Xia et al., 2002). siRNA 
has been delivered into brain, spinal cord and muscle with lentiviruses as well (Raoul et al., 
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2005, Peng and Masliah, 2010). With these techniques, we should be able to analyze the role of 
miR-431 in peripheral nerve regeneration in vivo. 
In the past decade, since the post-transcriptional regulation of gene expression was 
discovered, there has been rapid progress in deciphering the mechanisms underlying miRNA 
pathway. However, we are only at the initial stage of understanding the role of miRNA pathway 
in nerve injury and regeneration. As a mediator of gene silencing, miRNA has shown therapeutic 
efficacy in animal models of neurological conditions. Studies deciphering the functions mediated 
by miRNAs will have great significance in understanding basic cellular mechanism as well as 
inspiring miRNA based therapeutics. 
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